WO2003017753A2 - Reverse breeding - Google Patents
Reverse breedingInfo
- Publication number
- WO2003017753A2 WO2003017753A2 PCT/EP2002/009526 EP0209526W WO03017753A2 WO 2003017753 A2 WO2003017753 A2 WO 2003017753A2 EP 0209526 W EP0209526 W EP 0209526W WO 03017753 A2 WO03017753 A2 WO 03017753A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- target gene
- plant
- recombination
- plants
- homozygous
- Prior art date
Links
- 230000002441 reversible effect Effects 0.000 title claims description 31
- 230000001488 breeding effect Effects 0.000 title description 36
- 238000009395 breeding Methods 0.000 title description 35
- 230000006798 recombination Effects 0.000 claims abstract description 124
- 238000005215 recombination Methods 0.000 claims abstract description 124
- 210000000349 chromosome Anatomy 0.000 claims abstract description 123
- 238000000034 method Methods 0.000 claims abstract description 119
- 238000004519 manufacturing process Methods 0.000 claims abstract description 41
- 210000003783 haploid cell Anatomy 0.000 claims abstract description 31
- 241000282414 Homo sapiens Species 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 253
- 108020004414 DNA Proteins 0.000 claims description 57
- 230000014509 gene expression Effects 0.000 claims description 44
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 36
- 230000000295 complement effect Effects 0.000 claims description 34
- 230000030279 gene silencing Effects 0.000 claims description 34
- 239000002773 nucleotide Substances 0.000 claims description 31
- 125000003729 nucleotide group Chemical group 0.000 claims description 31
- 230000001629 suppression Effects 0.000 claims description 31
- 230000002068 genetic effect Effects 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 26
- 108091034117 Oligonucleotide Proteins 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 101000968663 Homo sapiens MutS protein homolog 5 Proteins 0.000 claims description 20
- 102100021156 MutS protein homolog 5 Human genes 0.000 claims description 19
- 230000009368 gene silencing by RNA Effects 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 18
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 16
- 230000035772 mutation Effects 0.000 claims description 15
- 230000002452 interceptive effect Effects 0.000 claims description 13
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 230000001939 inductive effect Effects 0.000 claims description 11
- 102000039446 nucleic acids Human genes 0.000 claims description 11
- 108020004707 nucleic acids Proteins 0.000 claims description 11
- 230000002265 prevention Effects 0.000 claims description 11
- 238000013518 transcription Methods 0.000 claims description 11
- 230000035897 transcription Effects 0.000 claims description 11
- 208000036878 aneuploidy Diseases 0.000 claims description 10
- 231100001075 aneuploidy Toxicity 0.000 claims description 10
- 206010021929 Infertility male Diseases 0.000 claims description 9
- 208000007466 Male Infertility Diseases 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 9
- 231100000350 mutagenesis Toxicity 0.000 claims description 9
- 230000028604 virus induced gene silencing Effects 0.000 claims description 9
- 230000001086 cytosolic effect Effects 0.000 claims description 8
- 230000005782 double-strand break Effects 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 108020005544 Antisense RNA Proteins 0.000 claims description 5
- 108091033380 Coding strand Proteins 0.000 claims description 5
- 108091023040 Transcription factor Proteins 0.000 claims description 5
- 102000040945 Transcription factor Human genes 0.000 claims description 5
- 230000008827 biological function Effects 0.000 claims description 5
- 239000003184 complementary RNA Substances 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims description 5
- -1 DMCl Proteins 0.000 claims description 4
- 102100038191 Double-stranded RNA-specific editase 1 Human genes 0.000 claims description 4
- 101000742223 Homo sapiens Double-stranded RNA-specific editase 1 Proteins 0.000 claims description 4
- 101000836826 Homo sapiens Protein shortage in chiasmata 1 ortholog Proteins 0.000 claims description 4
- 101000693444 Homo sapiens Zinc transporter ZIP2 Proteins 0.000 claims description 4
- 101000686491 Platymeris rhadamanthus Venom redulysin 1 Proteins 0.000 claims description 4
- 101100459664 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) NAM8 gene Proteins 0.000 claims description 4
- 102100025451 Zinc transporter ZIP2 Human genes 0.000 claims description 4
- 101150101590 hop-1 gene Proteins 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 108020004999 messenger RNA Proteins 0.000 claims description 4
- 102100039116 DNA repair protein RAD50 Human genes 0.000 claims description 3
- 102100029952 Double-strand-break repair protein rad21 homolog Human genes 0.000 claims description 3
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 claims description 3
- 101000743929 Homo sapiens DNA repair protein RAD50 Proteins 0.000 claims description 3
- 101000584942 Homo sapiens Double-strand-break repair protein rad21 homolog Proteins 0.000 claims description 3
- 101000968674 Homo sapiens MutS protein homolog 4 Proteins 0.000 claims description 3
- 101000693447 Homo sapiens Zinc transporter ZIP1 Proteins 0.000 claims description 3
- 102100021157 MutS protein homolog 4 Human genes 0.000 claims description 3
- ZRKWMRDKSOPRRS-UHFFFAOYSA-N N-Methyl-N-nitrosourea Chemical compound O=NN(C)C(N)=O ZRKWMRDKSOPRRS-UHFFFAOYSA-N 0.000 claims description 3
- 101100409457 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CDC40 gene Proteins 0.000 claims description 3
- 101100156959 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) XRS2 gene Proteins 0.000 claims description 3
- 102100025452 Zinc transporter ZIP1 Human genes 0.000 claims description 3
- 238000003205 genotyping method Methods 0.000 claims description 3
- 238000002744 homologous recombination Methods 0.000 claims description 3
- 230000006801 homologous recombination Effects 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 210000001161 mammalian embryo Anatomy 0.000 claims description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 3
- UKIDUMMXBQMTKO-UHFFFAOYSA-N 1-methyl-1-nitro-2-nitrosoguanidine Chemical compound [O-][N+](=O)N(C)C(=N)NN=O UKIDUMMXBQMTKO-UHFFFAOYSA-N 0.000 claims description 2
- NUKQEEMKQGMUQH-UHFFFAOYSA-N 1-methyl-1-nitrosoguanidine Chemical compound O=NN(C)C(N)=N NUKQEEMKQGMUQH-UHFFFAOYSA-N 0.000 claims description 2
- 101100326202 Caenorhabditis elegans him-6 gene Proteins 0.000 claims description 2
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 claims description 2
- 102100037700 DNA mismatch repair protein Msh3 Human genes 0.000 claims description 2
- 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 claims description 2
- 102100024455 DNA repair protein SWI5 homolog Human genes 0.000 claims description 2
- 102100029716 DnaJ homolog subfamily A member 3, mitochondrial Human genes 0.000 claims description 2
- 101710146526 Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 claims description 2
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 2
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 claims description 2
- 101001027762 Homo sapiens DNA mismatch repair protein Msh3 Proteins 0.000 claims description 2
- 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 claims description 2
- 101000832371 Homo sapiens DNA repair protein SWI5 homolog Proteins 0.000 claims description 2
- 101000866012 Homo sapiens DnaJ homolog subfamily A member 3, mitochondrial Proteins 0.000 claims description 2
- 101001025416 Homo sapiens Homologous-pairing protein 2 homolog Proteins 0.000 claims description 2
- 101000575211 Homo sapiens Meiosis-specific protein MEI4 Proteins 0.000 claims description 2
- 101001078144 Homo sapiens Meiotic recombination protein REC114 Proteins 0.000 claims description 2
- 101001099308 Homo sapiens Meiotic recombination protein REC8 homolog Proteins 0.000 claims description 2
- 101000738901 Homo sapiens PMS1 protein homolog 1 Proteins 0.000 claims description 2
- 101000708766 Homo sapiens Structural maintenance of chromosomes protein 3 Proteins 0.000 claims description 2
- 101000651041 Homo sapiens Swi5-dependent recombination DNA repair protein 1 homolog Proteins 0.000 claims description 2
- 101000904868 Homo sapiens Transcriptional regulator ATRX Proteins 0.000 claims description 2
- 102100037898 Homologous-pairing protein 2 homolog Human genes 0.000 claims description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 2
- 229940124647 MEK inhibitor Drugs 0.000 claims description 2
- 229910015837 MSH2 Inorganic materials 0.000 claims description 2
- 102100025630 Meiosis-specific protein MEI4 Human genes 0.000 claims description 2
- 102100025309 Meiotic recombination protein REC114 Human genes 0.000 claims description 2
- 102100038882 Meiotic recombination protein REC8 homolog Human genes 0.000 claims description 2
- FUSGACRLAFQQRL-UHFFFAOYSA-N N-Ethyl-N-nitrosourea Chemical compound CCN(N=O)C(N)=O FUSGACRLAFQQRL-UHFFFAOYSA-N 0.000 claims description 2
- 101100355599 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) mus-11 gene Proteins 0.000 claims description 2
- 102100037482 PMS1 protein homolog 1 Human genes 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 claims description 2
- 101150006234 RAD52 gene Proteins 0.000 claims description 2
- 101150104689 REC102 gene Proteins 0.000 claims description 2
- 101150102749 REC104 gene Proteins 0.000 claims description 2
- 102000002490 Rad51 Recombinase Human genes 0.000 claims description 2
- 108010068097 Rad51 Recombinase Proteins 0.000 claims description 2
- 102000053062 Rad52 DNA Repair and Recombination Human genes 0.000 claims description 2
- 108700031762 Rad52 DNA Repair and Recombination Proteins 0.000 claims description 2
- 101100400993 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MEK1 gene Proteins 0.000 claims description 2
- 101100523530 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RAD55 gene Proteins 0.000 claims description 2
- 101100523532 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RAD57 gene Proteins 0.000 claims description 2
- 101100033336 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) REC107 gene Proteins 0.000 claims description 2
- 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 claims description 2
- 102100032723 Structural maintenance of chromosomes protein 3 Human genes 0.000 claims description 2
- 102100027777 Swi5-dependent recombination DNA repair protein 1 homolog Human genes 0.000 claims description 2
- 102100023931 Transcriptional regulator ATRX Human genes 0.000 claims description 2
- 230000000368 destabilizing effect Effects 0.000 claims description 2
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 claims description 2
- 229940008406 diethyl sulfate Drugs 0.000 claims description 2
- 229960000286 proflavine Drugs 0.000 claims description 2
- 230000001177 retroviral effect Effects 0.000 claims description 2
- 108091030071 RNAI Proteins 0.000 claims 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims 2
- 230000005026 transcription initiation Effects 0.000 claims 2
- 230000005030 transcription termination Effects 0.000 claims 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 1
- 102100033996 Double-strand break repair protein MRE11 Human genes 0.000 claims 1
- 101000591400 Homo sapiens Double-strand break repair protein MRE11 Proteins 0.000 claims 1
- 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 303
- 210000004027 cell Anatomy 0.000 description 70
- 241000894007 species Species 0.000 description 50
- 239000012634 fragment Substances 0.000 description 46
- 238000005516 engineering process Methods 0.000 description 27
- 230000021121 meiosis Effects 0.000 description 26
- 230000009466 transformation Effects 0.000 description 25
- 230000015572 biosynthetic process Effects 0.000 description 23
- 238000004458 analytical method Methods 0.000 description 21
- 241000219194 Arabidopsis Species 0.000 description 19
- 240000008042 Zea mays Species 0.000 description 19
- 238000011282 treatment Methods 0.000 description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 235000011331 Brassica Nutrition 0.000 description 15
- 241000219198 Brassica Species 0.000 description 15
- 230000004048 modification Effects 0.000 description 15
- 238000012986 modification Methods 0.000 description 15
- 238000003976 plant breeding Methods 0.000 description 15
- 230000009261 transgenic effect Effects 0.000 description 15
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 14
- 241000219195 Arabidopsis thaliana Species 0.000 description 14
- 230000008774 maternal effect Effects 0.000 description 14
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 13
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 13
- 238000013459 approach Methods 0.000 description 13
- 230000002759 chromosomal effect Effects 0.000 description 13
- 230000003828 downregulation Effects 0.000 description 13
- 230000036961 partial effect Effects 0.000 description 13
- 239000013598 vector Substances 0.000 description 13
- 108700028369 Alleles Proteins 0.000 description 12
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 12
- 235000009973 maize Nutrition 0.000 description 12
- 239000003550 marker Substances 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 240000008067 Cucumis sativus Species 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000002299 complementary DNA Substances 0.000 description 11
- 235000013601 eggs Nutrition 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 10
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 10
- 240000007594 Oryza sativa Species 0.000 description 10
- 235000007164 Oryza sativa Nutrition 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 10
- 235000002597 Solanum melongena Nutrition 0.000 description 10
- 244000061458 Solanum melongena Species 0.000 description 10
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 10
- 244000000626 Daucus carota Species 0.000 description 9
- 235000002767 Daucus carota Nutrition 0.000 description 9
- 235000021536 Sugar beet Nutrition 0.000 description 9
- 230000022600 negative regulation of reciprocal meiotic recombination Effects 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 235000009566 rice Nutrition 0.000 description 9
- 210000000130 stem cell Anatomy 0.000 description 9
- 101000968669 Arabidopsis thaliana DNA mismatch repair protein MSH5 Proteins 0.000 description 8
- 240000007124 Brassica oleracea Species 0.000 description 8
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 8
- 108091060290 Chromatid Proteins 0.000 description 8
- 210000004756 chromatid Anatomy 0.000 description 8
- 230000008488 polyadenylation Effects 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 8
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
- 241000589158 Agrobacterium Species 0.000 description 7
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 7
- 240000003768 Solanum lycopersicum Species 0.000 description 7
- 229960001338 colchicine Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000008775 paternal effect Effects 0.000 description 7
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 7
- 238000003757 reverse transcription PCR Methods 0.000 description 7
- 230000002103 transcriptional effect Effects 0.000 description 7
- 240000002791 Brassica napus Species 0.000 description 6
- 244000020551 Helianthus annuus Species 0.000 description 6
- 235000003222 Helianthus annuus Nutrition 0.000 description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 6
- 244000061176 Nicotiana tabacum Species 0.000 description 6
- 241000220259 Raphanus Species 0.000 description 6
- 108700019146 Transgenes Proteins 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 230000000692 anti-sense effect Effects 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 238000012226 gene silencing method Methods 0.000 description 6
- 230000007614 genetic variation Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000010369 molecular cloning Methods 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 108010058731 nopaline synthase Proteins 0.000 description 6
- 230000000644 propagated effect Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000005204 segregation Methods 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 5
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 5
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 5
- 244000241257 Cucumis melo Species 0.000 description 5
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 5
- 240000005979 Hordeum vulgare Species 0.000 description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 5
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 229960001948 caffeine Drugs 0.000 description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 210000000805 cytoplasm Anatomy 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000009399 inbreeding Methods 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 210000001672 ovary Anatomy 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 230000010153 self-pollination Effects 0.000 description 5
- 210000004217 synaptonemal complex Anatomy 0.000 description 5
- 241000234282 Allium Species 0.000 description 4
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 4
- 235000005156 Brassica carinata Nutrition 0.000 description 4
- 244000257790 Brassica carinata Species 0.000 description 4
- 235000006008 Brassica napus var napus Nutrition 0.000 description 4
- 241000244203 Caenorhabditis elegans Species 0.000 description 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 4
- 108010025815 Kanamycin Kinase Proteins 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 230000023428 female meiosis Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000023386 male meiosis Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 210000001082 somatic cell Anatomy 0.000 description 4
- 229960000268 spectinomycin Drugs 0.000 description 4
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 4
- 229960005322 streptomycin Drugs 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 244000003416 Asparagus officinalis Species 0.000 description 3
- 235000005340 Asparagus officinalis Nutrition 0.000 description 3
- 235000011302 Brassica oleracea Nutrition 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
- 108091064358 Holliday junction Proteins 0.000 description 3
- 102000039011 Holliday junction Human genes 0.000 description 3
- 239000006002 Pepper Substances 0.000 description 3
- 235000016761 Piper aduncum Nutrition 0.000 description 3
- 240000003889 Piper guineense Species 0.000 description 3
- 235000017804 Piper guineense Nutrition 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000010165 autogamy Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 3
- 229960005420 etoposide Drugs 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 208000021267 infertility disease Diseases 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000011278 mitosis Effects 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- 210000000633 nuclear envelope Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000010152 pollination Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000003104 tissue culture media Substances 0.000 description 3
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 2
- 101100444285 Arabidopsis thaliana DYAD gene Proteins 0.000 description 2
- 235000011303 Brassica alboglabra Nutrition 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 2
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 2
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 2
- 244000308180 Brassica oleracea var. italica Species 0.000 description 2
- 241000220243 Brassica sp. Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 240000006740 Cichorium endivia Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 239000005983 Maleic hydrazide Substances 0.000 description 2
- BGRDGMRNKXEXQD-UHFFFAOYSA-N Maleic hydrazide Chemical compound OC1=CC=C(O)N=N1 BGRDGMRNKXEXQD-UHFFFAOYSA-N 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 2
- KYRVNWMVYQXFEU-UHFFFAOYSA-N Nocodazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CS1 KYRVNWMVYQXFEU-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- 239000010103 Podophyllin Substances 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 208000005652 acute fatty liver of pregnancy Diseases 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000009418 agronomic effect Effects 0.000 description 2
- 230000031016 anaphase Effects 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- HKPHPIREJKHECO-UHFFFAOYSA-N butachlor Chemical compound CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC HKPHPIREJKHECO-UHFFFAOYSA-N 0.000 description 2
- 210000002230 centromere Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000003733 chicria Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000002380 cytological effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 2
- 229960003529 diazepam Drugs 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960003913 econazole Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 2
- 229960002867 griseofulvin Drugs 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000000442 meristematic effect Effects 0.000 description 2
- 230000031864 metaphase Effects 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 229950006344 nocodazole Drugs 0.000 description 2
- 231100000208 phytotoxic Toxicity 0.000 description 2
- 230000000885 phytotoxic effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229940068582 podophyllin Drugs 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 2
- 229960000611 pyrimethamine Drugs 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000016853 telophase Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 2
- 239000004308 thiabendazole Substances 0.000 description 2
- 229960004546 thiabendazole Drugs 0.000 description 2
- 235000010296 thiabendazole Nutrition 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000009417 vegetative reproduction Effects 0.000 description 2
- 238000013466 vegetative reproduction Methods 0.000 description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- 101150025516 ASK1 gene Proteins 0.000 description 1
- 101710197633 Actin-1 Proteins 0.000 description 1
- 101710196039 Actin-11 Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 101100292208 Arabidopsis thaliana MSH5 gene Proteins 0.000 description 1
- 101100186130 Arabidopsis thaliana NAC052 gene Proteins 0.000 description 1
- 101100529509 Arabidopsis thaliana RECQL4A gene Proteins 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001465180 Botrytis Species 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 102100027674 CTD small phosphatase-like protein Human genes 0.000 description 1
- 101710156847 CTD small phosphatase-like protein Proteins 0.000 description 1
- 241000244202 Caenorhabditis Species 0.000 description 1
- 101100220616 Caenorhabditis elegans chk-2 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 235000009831 Citrullus lanatus Nutrition 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 108091027551 Cointegrate Proteins 0.000 description 1
- 102100033832 Crossover junction endonuclease EME1 Human genes 0.000 description 1
- 235000009842 Cucumis melo Nutrition 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- VUDQSRFCCHQIIU-UHFFFAOYSA-N DIF1 Natural products CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 1
- 101150001108 DIF1 gene Proteins 0.000 description 1
- 108050008316 DNA endonuclease RBBP8 Proteins 0.000 description 1
- 102100028849 DNA mismatch repair protein Mlh3 Human genes 0.000 description 1
- 230000008265 DNA repair mechanism Effects 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 108050007511 Ddc1 Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241001303048 Ditta Species 0.000 description 1
- 101150072707 EME1 gene Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000552068 Eucarpia Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 102100035111 Farnesyl pyrophosphate synthase Human genes 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 101100264215 Gallus gallus XRCC6 gene Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 108010026318 Geranyltranstransferase Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 101100175482 Glycine max CG-3 gene Proteins 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000577867 Homo sapiens DNA mismatch repair protein Mlh3 Proteins 0.000 description 1
- 101000949825 Homo sapiens Meiotic recombination protein DMC1/LIM15 homolog Proteins 0.000 description 1
- 101001128138 Homo sapiens NACHT, LRR and PYD domains-containing protein 2 Proteins 0.000 description 1
- 101000981336 Homo sapiens Nibrin Proteins 0.000 description 1
- 101000843497 Homo sapiens Probable ATP-dependent DNA helicase HFM1 Proteins 0.000 description 1
- 101001046894 Homo sapiens Protein HID1 Proteins 0.000 description 1
- 101000904787 Homo sapiens Serine/threonine-protein kinase ATR Proteins 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101150059802 KU80 gene Proteins 0.000 description 1
- 229920003266 Leaf® Polymers 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 102100031897 NACHT, LRR and PYD domains-containing protein 2 Human genes 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 101710178747 Phosphatidate cytidylyltransferase 1 Proteins 0.000 description 1
- 102100033126 Phosphatidate cytidylyltransferase 2 Human genes 0.000 description 1
- 101710178746 Phosphatidate cytidylyltransferase 2 Proteins 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100030730 Probable ATP-dependent DNA helicase HFM1 Human genes 0.000 description 1
- 102100022877 Protein HID1 Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 102100035250 SUMO-activating enzyme subunit 2 Human genes 0.000 description 1
- 101150016929 SWI1 gene Proteins 0.000 description 1
- 101150042933 SYN1 gene Proteins 0.000 description 1
- 101100291465 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MMS4 gene Proteins 0.000 description 1
- 101001099297 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Meiotic recombination protein REC8 Proteins 0.000 description 1
- 101100203168 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SGS1 gene Proteins 0.000 description 1
- 101100366474 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rec12 gene Proteins 0.000 description 1
- 102100023921 Serine/threonine-protein kinase ATR Human genes 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241001661355 Synapsis Species 0.000 description 1
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 1
- 102100036973 X-ray repair cross-complementing protein 5 Human genes 0.000 description 1
- 102100036976 X-ray repair cross-complementing protein 6 Human genes 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 108091007916 Zinc finger transcription factors Proteins 0.000 description 1
- 102000038627 Zinc finger transcription factors Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000010154 cross-pollination Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000021953 cytokinesis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000009307 diakinesis Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000030699 diplotene Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 231100000502 fertility decrease Toxicity 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 229940065638 intron a Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 101150085005 ku70 gene Proteins 0.000 description 1
- 230000012470 leptotene Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000023439 meiosis II Effects 0.000 description 1
- 230000008627 meiotic prophase Effects 0.000 description 1
- 230000032969 meiotic prophase I Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000033607 mismatch repair Effects 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 101150096888 msh-5 gene Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000010765 pachytene Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000008186 parthenogenesis Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000031877 prophase Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 230000018883 protein targeting Effects 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000023455 reciprocal meiotic recombination Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000001743 silencing effect Effects 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012225 targeting induced local lesions in genomes Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012090 tissue culture technique Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 230000009353 zygotene Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
Definitions
- This invention relates to a method for efficiently producing homozygous organisms from a heterozygous non-human starting organism.
- the invention relates in particular to the use of this method in plant breeding to produce parental lines for the production of hybrid offspring.
- the invention further relates to DNA constructs for use in this method, to primer pairs to select genes for use in this method, to Fl hybrid organisms obtainable by crossing organisms that are the result of the method and to seeds resulting from the method.
- Hybrid varieties Plant breeding is one of the oldest accomplishments of man. It began when he domesticated plants by growing them under controlled conditions and selecting those types that provided a dependable source of food. The most important feature contributing to high yield of many new varieties is their hybrid nature. The most dramatic example is hybrid corn, which was first introduced in significant amounts in 1932 and now makes up about 95% of the acreage of corn in the united States. Hybrid varieties are now available in crops such as sorghum, sugar beet, sunflower, onions, castor beans, oilseed rape, leek, cucumber, tomato, spinach, melon, pepper, carrot, cabbage, cauliflower, broccoli, radish, egg plant etc., in fungi, such as mushrooms, and in animals, such as poultry and fish.
- J. Sneep and A. Hendriksen (1979, Pudoc, Centre for Agricultural Publishing and Documentation ageningen) teach several methods for plant breeding which have been successfully applied during the last decades and which result in the varieties that are grown nowadays.
- Chapter "Current breeding methods”, J. Sneep and A. Hendriksen (1979) (supra, pp 104-233) describe general breeding techniques but also the specific breeding technologies for a number of crops, such as potato, sugar beet, maize, sunflower etc.
- selections are made from a collection of plants that can be derived from seeds from the market (commercial varieties) , gene bank accessions, land races etc. From this collection, the "best" plants are selected and crossed according to the art. So traditionally, pure lines or homogenous populations are obtained by breeding.
- Plant breeding has the objective to produce improved crop varieties based on the exploitation of genetic variation, which exists within the germ plasm of a plant species. Genetic variation is traditionally obtained by crossing two genetically distinct plants to create hybrid progeny.
- the genotype of a progeny plant is the result of the combination of the genotypes of the male and female gamete, which through fusion resulted in a zygote, from which ultimately the progeny plant developed.
- Gametes are formed by the gametophytic generation during the life cycle of a plant and therefore the genetic variation of the gametes is reflected in the genotypes of the gametophytes .
- Gametophytes differentiate from spores, which are produced by the sporophytic generation during the life cycle of the plant. Spores are produced from differentiated cells in the reproductive organs of a plant through a specialized cell division process called meiosis.
- chromosomal segregation and recombination are the processes which cause independent re-assortment and the generation of new combinations of the genetic factors of a diploid genome into a haploid genome of the gametophytes .
- the genotype of one progeny plant is the combination of genotypes of one male and one female gamete, which fused to form a new sporophyte.
- Meiosis can therefore be considered to be a pivotal process during the life cycle of any living organism to create genetic variability. This variability is used to obtain desired plants with new properties.
- the combination of the different properties of the two parents in a hybrid is more advantageous than a homozygous (parental) plant. The production of such hybrids is however rather complicated.
- Fl hybrids In the case of Fl hybrids, several putative parental lines are first made homozygous, e.g. by many generations of inbreeding and selection and subsequently they are crossed in various combinations to study their combining ability. The best combinations and their respective parental lines are subsequently retained and give rise to a commercial Fl variety.
- hybrids may be desirable but since animals take an even longer time to become sexually mature and reproduce it takes even longer to produce homozygous lines and select for the best combination of those to produce a hybrid.
- animals for which the invention may be useful include rainbow trout and aquarium fish such as zebrafish. Summary of the invention
- the reverse of traditional breeding is possible, i.e. starting with the heterozygous plant to produce homozygous parental lines.
- the homozygous parental lines can reconstitute the original heterozygous plant or animal by crossing, if desired even in a large quantity.
- An individual heterozygous plant can surprisingly be converted in a heterozygous (Fl-hybrid) variety without the necessity of vegetative propagation but as the result of the cross of 2 homozygous lines derived from the original selected plant.
- the present invention thus relates to a method for efficiently producing homozygous organisms from a heterozygpus non-human starting organism, comprising: a) providing a heterozygous starting organism; b) allowing the starting organism to produce haploid cells; c) creating homozygous organisms from the haploid cells thus obtained; and d) selecting the organisms having the desired set of chromosomes; characterized in that during production of the haploid cells essentially no recombination occurs in order to obtain a limited number of different haploid cells.
- recombination is at least partially prevented or suppressed in contrast to situations in which the starting organism is selected for its inability to have recombination upon the formation of haploid cells.
- the method can be used for plants, fungi and animals except humans.
- the "desired set of chromosomes" can be one of a number of. variants.
- the two homozygous organisms produced according to the invention should together have the exact set of chromosomes of the starting organism. This is achieved when both parents have the same set of ' chromosomes as the gametes that formed the hybrid.
- the new maternal line has only some of the chromosomes of the original maternal gamete and the others of the original paternal gamete ("chromosome substitution"). In that case the other parent should again have the complement thereof if the production of the same hybrid is desired.
- the new line which has one or more but not all of the chromosomes of the original parent with a different parent in plant breeding.
- the new homozygous lines as such can thus be a newly desired end product. This applies to lines having the original parental chromosome composition as well as to lines having a new combination of chromosomes. Recombination can be prevented or suppressed by various means, in particular through dominant transgenic approaches, dominant negative mutation or treatment with a chemical.
- the prevention or suppression of recombination is achieved by interfering with one or more target genes involved in recombination.
- the target genes can be involved in double strand breaks, chromosome pairing, crossing-over and separation of sister chromatids.
- Target genes (GenBank accession nos.) involved in the formation of double strand breaks are SPOll (J02987.1), MERl (M31304.1), MER2 (M38340.1), MRE2 (D11461.1), MEI4 (M84765.1), REC102 (M74045.1), REC104 (Z15007.1), REC114 (Z14315.1), MEK1/MRE4 (X63112.1), RED1 (X16183.1), HOP1 (J04877.1), RAD50 (X14814.1), MREll (U60829.1), XRS2 (L22856.1), identified in yeast, or their functional homologues from other species.
- Target genes involved in chromosome pairing and/or strand exchange are RAD54/TID1 (M63232.1), DMC1 (M87549.1), MNDl (protein accession NP_011332.1) , SAE2 (U49447.1), SAE3 (U82546.1), RED1 (X16183.1), HOP1 (J04877.1), HOP2 (AF078740.1) , REC8 (AJ223299.1) , MERl (M31304.1), MRE2 (D11461.1), ZIP1 (L06487.1), ZIP2 (protein accession: NP 011265.1), MEI5 ( 03182.1), RAD51 (X64270.1), RAD52 (M10249.1), RAD55 (U01144.1), RAD57 (M65061.1), RPA (M60262.1), SMC3 (Y14278.1), SCC1 (Y14280.1), MSH2 (M84170.1), MSH3 (M96250.1), MSH6
- recombination complexes After recombination complexes are formed (double holliday junctions) these are processed to either crossing- over events or non-crossing-over events (called gene conversion) . Most recombination complexes lead to gene conversion, whereas only a few crossing-over events lead to recombination.
- Target genes selected from the group consisting of SGS1 (U22341.1), MSH4 (U13999.1), MSH5 (L42517.1), ZIPl (L06487.1), ZIP2 (protein accession: NP_011265.1) , MLH1 (U07187.1.), MEC1 (U31109.1), MLH3 (protein accession NP_015161.1) from yeast, or their functional homologues from other species.
- a (candidate) target gene is defined as a gene residing within the genome of an organism which upon quantitative and/or qualitative modification of its expression results in a modified meiotic process within said organism which is characterized by the formation of functional, haploid spores that contain a full set of chromosomes but which have not been subjected to meiotic recombination or which have been subjected to a reduced frequency of meiotic recombination as compared to the situation in which said gene is not modified.
- a first embodiment interfering with the target gene consists of preventing transcription thereof. This can be achieved by means of RNA oligonucleotides, DNA oligonucleotides or RNAi molecules directed against the target gene promoter.
- transcription is prevented by means of the expression of a negatively acting transcription factor acting on the target gene promoter.
- a negatively acting transcription factor can be natural or artificial.
- Artificial negatively acting transcription factors can be employed by the overexpression of an engineered polydactyl zinc-finger transcription factor coupled to a general transcription repressor .
- the interfering with the target gene consists of destabilizing the target gene RNA, in particular by means of nucleic acid molecules that are complementary to the target gene mRNA selected from the group consisting of antisense RNA, RNAi molecules, Virus Induced Gene Silencing (VIGS) molecules, co-suppressor molecules, RNA oligonucleotides or DNA oligonucleotides.
- nucleic acid molecules that are complementary to the target gene mRNA selected from the group consisting of antisense RNA, RNAi molecules, Virus Induced Gene Silencing (VIGS) molecules, co-suppressor molecules, RNA oligonucleotides or DNA oligonucleotides.
- VIPGS Virus Induced Gene Silencing
- the interfering with the target gene consists of inhibiting the target gene expression product. This can be achieved by means of the expression product (s) of one or more dominant negative ' nucleic acid constructs, overexpression of one or more suppressors which interact with the target gene product, or by means of one or more chemical compounds.
- interfering with the target gene can consist of the introduction of one or more mutations into the target gene leading to perturbation of its biological function.
- the one or more mutations can be introduced randomly by means of one or more chemical compounds and/or physical means and/or insertion of genetic elements.
- Suitable chemical .compounds are ethyl methanesulfonate, nitrosomethylurea, hydroxylamine, proflavine, N-methyl-N- nitrosoguanidine, N-ethyl-N-nitrosourea, N-methyl-N-nitro- nitrosoguanidine, diethyl sulfate, ethylene i ine, sodium ' azide, formaline, urethane, phenol and ethylene oxide.
- Physical means that can be used comprise UV-irradiation, fast-neutron exposure, X-rays and gamma irradiation.
- the genetic element is a transposon, T-DNA, or retroviral element. Mutations may also be introduced specifically by means of homologous recombination or oligonucleotide-based mutation induction.
- the prevention or suppression of recombination is achieved by a chemical compound preventing the spindle from being formed or by a chemical compound inducing aneuploidy.
- haploid cells After the starting plant has been treated such that recombination is prevented or suppressed before or while haploid cells are being formed, these cells are isolated and used for regeneration of a complete plant.
- Such plant is haploid and can become diploid either spontaneously or through other means, such as treatment with colchicine.
- Haploid cells can be derived from germ line cells such as spore mother cells or somatic cells that have become haploid by means of a natural or induced process.
- the haploid plant is diploidized it is homozygous for all chromosomes and it can be used for various purposes. It is possible to derive the chromosome composition of the original parents (so-called "original parental line rescue") of the hybrid that is the subject of reverse breeding by molecular analysis of either the seed coat or the endosperm.
- the endosperm contains a double maternal genetic dosage.
- a quantitative assay can be used to determine which chromosomes are derived from the mother (twice the dosage) and which from the father (once the dosage) .
- the seed coat is maternal and represents the chromosome composition that originates from the mother.
- the production of Fl hybrids can now be done in completely the reverse order.
- reverse breeding Instead of selecting so-called original parental lines, and testing suitable combinations, a heterozygous plant with an expected suitable combination of allelic forms of genes is selected, and corresponding parental lines that could be used for the production of Fl hybrid seeds of the same plant are derived from this plant.
- This process is herein called "reverse breeding”.
- reverse breeding technology allows a significant flexibility in the plant breeding process because in addition to the efficient reproduction of the exact starting genotype, for each individual chromosome a choice can be made to retrieve it either in a homozygous maternal, homozygous paternal or heterozygous form as will be explained hereinbelow.
- reverse breeding can be performed by preventing meiotic recombination in combination with efficiency enhancing methods for generating the parental lines, which in a preferred embodiment concerns the production of doubled haploid plants and/or molecular genotyping technologies.
- Other methods are second generation restitution and self pollination. In the latter case, plants in which recombination has been prevented or suppressed are selfed to produce selfing seed.
- Molecular genotyping techniques are then used to identify the homozygous plants in the SI.
- the invention thus relates to the prevention or suppression of recombination in a process for the production of haploid cells and to the production of homozygous lines from these cells.
- Haploid cells can be the result of meiosis or are derived from somatic cells. In the latter case chemical compounds can be used to haploidize the cells.
- reductional grouping is induced. In reductional grouping the chromosomes are distributed over the daughter cells without the help of the spindle fibres and without DNA replication. After cell division haploid cells are formed.
- Reductional grouping can be induced by treating (root) meristem or protoplasts with a chemical, such as caffeine or by neutralizing the genetic target of the chemical with a gene construct. Expression of the construct must be inducible because constitutive expression of the neutralizing construct would be lethal.
- haploid cells are however preferably derived from a meiotic process.
- the process of meiosis forms the pivotal event in the life cycle of living organisms at which genetic variation is created. Moreover it marks the transition between the diploid, sporophytic and the haploid, gametophytic generation which alternate during the life cycle of a plant.
- the specialized cell in the female reproductive organ which enters meiosis, which is called megaspore mother cell is embedded in the differentiated ovule inside the ovary. During ovule formation, a number of mitotic events lead to the differentiation of a single megaspore mother cell per ovule out of a few archesporial cells which develop from hypodermal cells.
- a few mutants of maize and Arabidopsis have been identified which are disturbed in the early functions of these differentiation processes.
- the macl (multiple archesporial cells) mutant of maize is disturbed in a gene that plays a role in the withdrawal of hypodermal cells from the mitotic into the meiotic pathway (Sheridan, W.F. et al (1999) Genetics 153, 933-941) .
- the spl (sporocyteless) mutant in Arabidopsis is disturbed in the differentiation of mega- and microspore mother cells from archesporial cells (Yang, W-C, et al (1999) Genes Dev. 13, 2108-2117) .
- meiocytes The macro- and microspore mother cells, collectively called meiocytes, undergo meiosis, which results in the formation of four haploid spores per meiocyte. Three of the four female spores or megaspores degenerate through callose deposition. The surviving megaspore differentiates after 3 nuclear divisions and subsequent cellularisation into the female gametophyte or embryosac.
- the four male spores or microspores usually remain together and form a so-called tetrad structure.
- the tetrad structure Upon differentiation of the male gametophytes from the microspores, the tetrad structure is dissolved and the male gametophytes or pollen behave as loose entities.
- meiotic Prophase a number of stages are discerned.
- Leptotene the individual chromosomes which have been replicated and which consist of two sister chromatids start to condense and become shorter and thicker.
- the nuclear envelope starts to disintegrate and the homologous chromosomes start to associate.
- Zygotene the chromosomes are fully condensed and in which the homologous chromosomes align and start to form the so-called synaptonemal complex (SC) .
- SC synaptonemal complex
- the difl/synl mutant of Arabidopsis is impaired in the formation of the SC (Bhatt, A.M.
- the DIF1/SYN1 gene products are homologous to the yeast cohesin REC8/RAD21 which function in synapsis and recombination.
- the DIF1/SYN1 gene products are homologous to the yeast cohesin REC8/RAD21 which function in synapsis and recombination.
- the formation of the SC is completed for all chromosomes.
- meiotic recombination occurs which is initiated by the formation of double-stranded breaks followed by chromatid exchange between homologous chromosomes.
- the physical links that are established between the non-sister chromatids and which persist even in the absence of the synaptonemal complex are called chiasmata.
- the chromosomes During Diplotene and Diakinesis the chromosomes fully condense, the nuclear envelope has disappeared and the spindle fibers have been formed. Subsequently during Metaphase I, the pairs of homologous chromosomes are located in the equatorial plane of the cell. Then, during Anaphase I, the homologous chromosomes, each consisting of two sister chromatids which may have undergone a number of recombination events and are held together by a centromere, move towards the opposite cellular poles. During Telophase I, the polar movement is completed, the spindle disappears and the cell starts to divide.
- these cells enter Prophase II that is characterized by the alignment of the condensed chromosomes on the equatorial plane.
- a spindle complex is being formed.
- Metaphase II the chromosomes are fully aligned at the equatorial plane and the spindle complex is completed.
- Anaphase II the centromeres divide and the sister chromatids move towards opposite poles.
- this movement process is completed, the spindle complex starts disappearing and cell division initiates.
- the chromosomes resume their Interphase appearance characterized by uncoiled chromosomes located inside the nuclear envelope.
- the end product of meiosis II is a set of four genetically distinct haploid cells, which can undergo mitosis to develop into gametophytes.
- the gametophytes produce the gametes, which upon fusion leads to the formation of a zygote, which develops, into an embryo that can grow out into the next generation sporophyte.
- the genetic variation which occurs in the sporophyte, is determined by the genotypes of the female and male gametes that fused upon the formation of the zygote. Therefore this genetic variation is created during the formation of the female and male spores during meiosis which leads to genetic re-assortment of the original parental chromosomes as well as chromosomal regions due to recombination events.
- DSB double strand break
- SPOll protein of yeast Homologues of the SPOll protein of yeast were found in Schizosaccharom.yces pom.be named REC12, Arabidopsis, Drosophila, Caenorhabditis, mouse and man. Arabidopsis is the only eukaryote known so far to contain 3 paralogous SPOll genes. The homology, which resides within the SPOll proteins, is confined to five conserved motifs.
- a Holliday junction resolution system can result in gene conversion or crossover.
- a large number of proteins has been identified which are involved in this process which can either be specific for meiotic recombination or can be involved in mitotic DSB and mismatch repair as well. Homologues of many of these proteins are being identified in plant systems like Arabidopsis thaliana and the corresponding genes have been cloned.
- the plant homologues of the SPOll protien have been identified in Arabidopsis thaliana and are named AtSPOll and AtDMCl (Couteau, F. et al (1999) Plant Cell 11, 1623-1634) . They are involved in bivalent stabilization and chromosomal segregation.
- recombination in the starting organism is to be prevented or suppressed.
- This prevention or suppression can be attained at various levels of the recombination event. No recombination can occur when no double strand breaks are produced, when the crossing-over is impaired and when the chromosomes cannot pair.
- Various genes are involved in all these events. Impairing the function of one or more of these genes leads to prevention (on/off) or suppression (lower level) of recombination. For the purpose of this application, such genes are called "(candidate) target genes".
- Interfering with the function of these genes can be achieved through a number of approaches which are either based on homology dependent gene silencing mechanisms such as co-suppression, antisense downregulation or RNA interference or which are based on expression of proteins which interfere with the functionality of the target protein.
- the latter method is for example downregulation through a dominant negative approach.
- the gene construct which is used to achieve the silencing effect should contain a DNA fragment which has a percentage of identity at the nucleotide level with a region of the target gene which is sufficient to downregulate this target gene to the extent that it results in the formation of viable, haploid spores that contain a full set of chromosomes which have not been subjected to meiotic recombination or which have been subjected to a reduced frequency of meiotic recombination as compared to the situation in which the target genes are not downregulated.
- This result can either be achieved after selecting a random fragment of the gene or by selecting those segments of the gene as silencing fragment which encode the conserved domains of the encoded protein.
- a fragment of the functional homologue of the gene itself can be used to achieve downregulation of this functional homologue within the crop species from which it has been derived.
- Functional homologues which reside in other crop species, can be downregulated using the silencing DNA fragment if there is sufficient homology.
- modification of the target genes is achieved by genetic engineering of the crop species .
- the nature of the modification of the target gene can either be downregulation, which means that the expression of the target gene is reduced or ectopic (over) expression, which means that the expression of the target gene is increased, and optionally taking place at a time different from the natural expression.
- ectopic (over) expression the target gene involved in recombina.tion has a repressor function.
- various methods can be used that are based on homology with the target gene.
- the downregulation of the target gene is achieved through a method referred to as antisense technology.
- a gene is expressed in its reversed orientation with respect to a transcriptional promoter.
- This can be achieved by introduction of a gene construct into the genome of a plant in which the segment of a gene, which is normally expressed as RNA, is reversed in its orientation relative to a transcriptional promoter.
- RNA segment of a gene
- antisense construct Usually such a construct is referred to as antisense construct.
- the plant produces RNA molecules that are synthesised using the coding strand of the gene construct as a template and therefore are complementary to the coding strand.
- antisense RNA is referred to as antisense RNA.
- the result of the expression of an antisense construct is that the gene or genes which reside in the same plant and which upon expression leads to the synthesis of RNA complementary to the antisense RNA are effectively silenced.
- the downregulation of the target gene is achieved through a method referred to as cosuppression technology.
- a gene is expressed in the sense orientation with respect to a transcriptional promoter. This can be achieved by introduction of a gene construct into the genome of a plant in which the segment of a gene which is normally expressed as RNA has the same orientation relative to a transcriptional promoter as in a native gene. Usually such construct is referred to as cosuppression or sense cosuppression construct.
- cosuppression construct Upon expression of the cosuppression construct in a plant, the plant produces RNA molecules that are synthesized using the non-coding strand of the gene construct as a template and therefore are complementary to the non-coding strand. Usually this type of RNA is referred to as cosuppression RNA.
- cosuppression RNA The result of the expression of a cosuppression construct is that the gene or genes which reside in the same plant and which upon expression leads to the synthesis of homologous RNA are effectively silenced.
- RNAi is a general term which refers to a phenomenon in which double stranded RNA (dsRNA) molecules very effectively mediate gene silencing of genes with homology to the dsRNA. Silencing of an endogenous gene triggered by dsRNA is the result of post transcriptional gene silencing which is a phenomenon in which an RNA transcript is synthesized and rapidly and specifically degraded.
- dsRNA double stranded RNA
- Silencing of an endogenous gene triggered by dsRNA is the result of post transcriptional gene silencing which is a phenomenon in which an RNA transcript is synthesized and rapidly and specifically degraded.
- RNAi has initially been demonstrated to operate in Caenorhabditis elegans (Fire, A. et al (1998) Nature 391, 806-811) .
- RNAi has also been demonstrated to be effective in other organisms including plants (Chuang, C-F. and Meyerowitz, E.M. (2000) Proc. Natl. Acad. Sci. USA 97, 4985-4990).
- Transgenes designed to express RNA which is self-complementary and thereby is able to form duplexes or hairpin RNAs were shown to be highly effective in triggering virus resistance and gene silencing (Smith, N. A. et al (2000) Nature 407, 319-320) .
- suppression of the target gene may be achieved through specific transcriptional silencing of the target gene via the promoter. This may be achieved through expression of an RNAi construct which results in the synthesis of double stranded RNA molecules of which the nucleotide sequence is identical to a part of the promoter region of the target gene.
- the promoter region of a gene is located upstream (with respect to the trancriptional direction) of the position at which transcription of the gene is initiated.
- suppression of the target gene may be achieved through a methodology generally referred to as Virus Induced Gene Silencing or VIGS (Ratcliff et al (2001) Plant J. 25, 237-245) .
- VIGS Virus Induced Gene Silencing
- effective and specific gene silencing is achieved by infection of a plant with a plant virus carrying an insert which is homologous to the gene which needs to be silenced.
- the advantage of the VIGS systems is that there is no need to develop a plant transformation protocol for the plant species for which silencing of a target gene is pursued.
- the silencing construct (antisense RNA, co-suppression, RNAi or hairpin construct or VIGS vector) preferably contains a DNA fragment that is identical to the target sequence (gene or promoter) that needs to be silenced.
- the percentage of identity may also range between 50 and 100 %, preferably between 60 and 100%, more preferably between 70 and 100%, even more preferably between 80 and 100%, most preferably between 90 and 100%.
- the length of the DNA fragment in the silencing construct should be at least 20 nucleotides but can also be longer to a maximum of the full-length target sequence which needs to be silenced.
- the transcriptional promoter which is used to synthesize the silencing molecule can be a constitutive promoter or a promoter which is developmentally regulated.
- the promoter may also be inducible for example by a chemical compound. preferably, but not necessarily the expression of the silencing construct and the target gene that needs to be silenced coincides. This does not apply to the silencing via the promoter of a gene because this approach is directed to avoiding transcription so that no transcript is formed.
- the other techniques neutralize the transcription product after it is produced.
- suppression of the target gene may be achieved through specific silencing of the target gene by introduction of RNA oligonucleotides (Tijsterman et al (2002) Science 295, 694-697) .
- This may be achieved through chemical synthesis of RNA oligonucleotides of which the nucleotide sequence is identical to a part of the promoter region or transcribed region of a target gene and introduction of the silencing oligonucleotides into the cell.
- the advantage of this specific embodiment of the invention is that there is no need to adopt a transgenic route in achieving reverse breeding for a specific target crop.
- the RNA oligonucleotide which is used to silence a target gene preferably has a nucleotide sequence which is identical to a part of the promoter or transcribed region of the target gene that needs to be silenced.
- the percentage of identity may also range between 50 and 100%, preferably between 70 and 100%, even more preferably between 80 and 100%, most preferably between 90 and 100%.
- the single stranded RNA oligonucleotide may be identical to either the sense or antisense strand of the DNA of the promoter or transcribed region of a target gene.
- single stranded RNA oligonucleotides instead of using single stranded RNA oligonucleotides, single stranded DNA oligonucleotides may be used of which the nucleotide sequence is designed as if it would be .an RNA oligonucleotide. Moreover both double stranded RNA as well as DNA oligonucleotides may be used.
- oligonucleotides can be introduced into plants or plant cells by methods well known to the person skilled in the art. These may include but are not limited to polyethylene mediated uptake in protoplasts or particle gun mediated uptake in plants or plant parts.
- homology based method like RNA interference, VIGS, oligonucleotides or others it is preferred to carry out a search for sequences that are homologous to the target sequence and that reside within the genome of the species to be subjected to recombination suppression or prevention.
- "Homologous” is intended to mean here "having a level of identity with the nucleic acid fragment which is used to effectuate the homology based suppression of the target gene that leads to suppression of the sequences outside the target gene” . In case such sequences are found it may be desirable to use another fragment of the target gene for design of the silencing sequence in order to avoid interference with other parts of the genome.
- suppression of the activity of the target gene may be achieved through overexpression of a dominant negative construct, a process well known to the person skilled in the art.
- a gene encoding a protein or modified protein is overexpressed in the crop species in which a target gene needs to be suppressed according to the present invention.
- the gene which encodes such a protein usually is referred to a dominant negative gene as the effect of (over) expression is inherited as a dominant genetic factor and it is causing a specific loss of function.
- the transcriptional promoter which is used to synthesize the dominant negative construct can be a constitutive promoter or a promoter which is developmentally regulated.
- the promoter of the dominant negative construct may also be inducible for example by a chemical compound.
- the expression of the dominant negative construct and the target gene that needs to be suppressed should be spatially and temporarily regulated such that the target gene is effectively suppressed.
- the promoter of the dominant negative construct and the target gene are regulated such that they are expressed in essentially the same part of the plant at essentially the same time.
- suppression of target genes is achieved through overexpression of a natural suppressor of the target gene.
- a suppressor may be a negatively acting transcription factor that acts on the promoter of target genes or a protein which interacts with the gene product of the target genes in such a way that this gene product can not fulfil its natural function.
- the expression of a suppressor construct and the target gene that needs to be suppressed should be spatially and temporarily regulated such that the target gene is effectively suppressed.
- the promoter of the suppresser construct and the target gene are regulated in an highly similar manner in terms of their spatial and temporal activity, i.e. they are expressed essentially at the same time in the same part of the plant.
- the promoter of the suppressor construct may also be inducible for example by a chemical compound.
- a silencing construct is used that modifies a target gene which specifically results in suppression of either female or male meiotic recombination. This can be achieved by interfering with the .activity of a gene product that is specifically active in either female or male meiotic recombination. Alternatively, this can be achieved by using a silencing construct that is specifically active during female or male meiosis. The latter kind of construct can either interfere with a target gene that is specifically involved in female or male meiotic recombination or a target gene that is involved in both female and male meiotic recombination.
- This specific embodiment of the invention has practical utility when the suppression of meiotic recombination leads to a reduction of the quality of the spores, such as a reduced number of functional haploid spores.
- Plants that are suppressed in female meiotic recombination but not in male meiotic recombination can be used as efficient pollinators to produce new hybrids and vice versa, the plants that are suppressed in male meiotic recombination can be used as efficient female lines during the production of new hybrids .
- chimeric gene constructs can be made using standard molecular cloning techniques well known to the person skilled in the art and which can for example be found in Sambrook, J and Russell, D.W. : Molecular cloning, a laboratory manual (third edition), Cold Spring Harbor Laboratory Press, Cold Spring
- constructs are "chimeric" in the sense that they consist of various DNA fragments originating from various sources.
- the chimeric constructs which are made to modify the activity, in particular transcription or translation, but also transcript processing, protein modification, protein targeting, complex formation and activity, of the target genes usually comprise a promoter sequence and a polyadenylation signal sequence that are operably linked to the DNA fragment that is being used to achieve suppression of meiotic recombination such that a functional chimeric gene construct is produced.
- transformation vectors are prepared using standard molecular cloning techniques well known to the person skilled in the art and which can for example be found in Sambrook, J and Russell, D.W. : Molecular cloning, a laboratory manual (third edition) , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
- Promoter sequences which can be used according to the present invention include but are not limited to constitutive promoters like the CaMV 35S promoter (Odell, J.T. et al (1985), Nature 313, 810-812), the Arabidopsis Act in 2 promoter (An, Y.Q. (1996) Plant J. 10, 107-121), the maize Ubiquitine 1 promoter (Drakakaki, G. et al (2000) Transgenic Res. 9, 445-452), the rice Actin 1 promoter (McElroy, D. et al (1990) Plant Cell 2, 163-171) and the Arabidopsis Farnesyl diphosphate synthase IS promoter (Cunillera, N. et al (2000) Plant Molec.
- promoters may be derived from the target gene itself.
- Inducible promoter systems which can be used are the ethanol inducible gene switch system (Caddick, M.X. et al (1998) Nat. Biotechnol. 16, 177- 180) and the glucocorticoid inducible system (Schena, M. et al (1991) Pore. Natl. Acad. Sci. USA.88, 10421-10425).
- Polyadenylation sequences which may be used in constructs of the present invention include but are not limited to the Agrobacterium octopine synthase polyadenylation signal (MacDonald et al (1991) Nucleic Acids. Res. 19, 5575-5581), the pea ribulose bisphophate carboxylase polyadenylation signal (Hunt, A.G. and MacDonald M.H. (1989) Plant Molec. Biol. 13,125-138).
- prevention or suppression of recombination can be achieved by randomly inducing changes in the genome of the organism and selecting those mutants that have acquired a change in the target gene that leads to the desired suppression or prevention of recombination.
- modification of the target genes is achieved by mutagenesis of the crop species. Random mutations can be introduced into a plant genome by chemical means like treatment with ethyl methanesulfonate or nitrosomethylurea, by Morphogenics technology (BioWorld Today (2000), 11(108), 1-2) or physical means like UV-irradiation, fast-neutron exposure or insertional mutagenesis using transposons or T-DNAs.
- a mutant is selected in which the modification of the target gene is conditional, which means that the mutant phenotype only becomes manifest upon exposure of the plant to a specific environmental condition like a specific temperature. This allows to induce the modification only by exposing the plant to the specific environment. Under the conditions in which the modification is not manifest, the mutant can be used for normal crossing and seed production.
- modification of the target genes is achieved by treatment of the crop species with specific chemical compounds which through interference with the products of the target genes result in inhibition or reduction of meiotic recombination.
- An example of such chemical compound is etoposide which through inhibition of the topoisomerase-II results in inhibition of meiotic recombination (Russell, L.B. et al (2000) Mutat. Res. 464, 201-212).
- aneuploidy can be induced chemically by treatment of pre-meiotic cells with certain chemical compounds. This may be done by chemical treatment of floral buds containing these pre-meiotic cells by submergence or spraying.
- Such method may effectively be applied to modify meiotic recombination as has been shown in patent application WO0054574.
- the mechanism by which a chemical compounds induces aneuploidy is not always clear but there is experimental evidence that aneuploidy can occur through interference with the spindle mechanism during mitosis and meiosis, fragmoplast function and chiasmata formation.
- the chemical that may be applied to induce aneuploidy is selected from but not limited to chemicals such as etoposide, podophyllin, benomyl, maleic hydrazide, atrazine,.
- spores can be isolated from the treated buds which can be induced to regenerate.
- Homozygous plants may be obtained through doubling of the chromosome number e.g. through treatment with colchicine in case spontaneous doubling has not been taken place already.
- the population of double haploid plants obtained through this method can be analysed for the presence of a full complement of chromosomes by molecular detection of marker alleles known to reside on a specific chromosome.
- Gynogenesis is particularly suitable for applying reverse breeding effectuated by chemical treatment.
- the specific chemical may be applied through the tissue culture medium used to apply gynogenesis. It may also be possible to treat the sterilised ovaries directly with the chemical compound that prevents meiotic recombination.
- the reason for this particular form of gynogenesis to be suitable for reverse breeding is that meiosis is still taking place in some if not all ovules of the ovary tissues taken as explant for the gynogenese tissue culture.
- haploids were the result of meiosis. However, -it is also possible to start with somatic cells for the production of haploid cells.
- the generation of plants containing unrecombined original parental chromosomes can be achieved by treatment of plants, plant organs or plant cells with chemical compounds like caffeine which result in chromosomal separation within a cell without the help of spindle fibers.
- the chromosomes separate evenly into two groups which after cytokinesis leads to haploid cells.
- the chromosomes in these cells can be doubled e.g. by colchicine in case spontaneous doubling has not been taken place already and regenerated into plants.
- chromosomes separate without recombination, their constitution is still the same as in the original parent. Furthermore, as haploid cells are formed, doubling of the chromosomal number leads to fully homozygous plants. However the distribution of the chromosomes is random and therefore the resulting homozygous plants can contain all possible combinations of maternal and paternal chromosomal pairs .
- This method is a specific embodiment of reverse breeding wherein somatic cells are used to produce progenitor cells which contain a haploid number of chromosomes which are unrecombined. This method is thus a form of reverse breeding in which there is no need to suppress meiotic recombination. This demonstrates that reverse breeding is a novel breeding concept which can be effectuated by seemingly different approaches .
- a silencing construct which upon expression in a target crop species modifies the expression of genes in a quantitative and/or qualitative way which can result in the formation- of viable, haploid spores that contain a full set of chromosomes which have not been subjected to meiotic recombination or which have been subjected to a reduced frequency of meiotic recombination as compared to the situation in which these genes are not modified, such construct needs to be transformed into the crop species which is to be treated according to the present invention.
- a well known plant transformation technology is based on the natural ability of a bacterial species called Agro acterium tumefaciens to deliver and stably integrate a segment of DNA into the genome of a plant cell (Zambryski, P. et al (1989) Cell 56, 193-201) .
- This piece of DNA, called T-DNA is usually located on a plasmid which resides inside the bacterial cell.
- the natural T-DNA does not contain functions important for DNA delivery or integration and can in principle be any DNA.
- the plasmid which contains the T-DNA can be a binary vector (Bevan, M. (1984) Nucleic Acids Res. 12, 8711-8721) or a cointegrate vector (Fraley, R. T. et al (1983) Proc. Natl . Acad. Sci. USA 80, 4803-4807).
- Agrobacterium cells which contain a plant transformation vector can be co-cultivated with explants derived from leafs or seedlings in order to deliver the T-DNA in cells present in the explant. (Horsch, R. et al (1985) Science 227, 1229- 1231) .
- T-DNA contains a selectable marker gene which upon expression in the transformed plant cell can confer resistance to a phytotoxic compound like the antibiotics kanamycin or hygromycin or the herbicides glyphosate or gluphosinate-ammonium. Addition of these phytotoxic compounds to the tissue culture medium during the regeneration of the cells of the explants prevents the outgrowth of untransformed cells or transformed cells which do not express the selectable marker gene to an insufficient extent.
- Transformants of crops that acquired a silencing construct are initially identified by their phenotype of resistance to the selective agent which has been used to obtain selective regeneration of transgenic cells expressing the selectable marker gene. Subsequently, the resistant transformants are further characterised molecularly to investigate the pattern of integration of the transformed DNA.
- Many techniques like polymerase chain reaction (PCR) or Southern blotting are available to carry out such an analysis and are well known to those skilled in the art (see for example techniques described Sambrook, J and Russell, D.W. : Molecular cloning, a laboratory manual (third edition, 2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York) .
- Those transformants that contain a single, intact copy, of the transformed DNA are preferably selected for further analysis.
- transformants containing multiple copies of the transformed DNA may be useful as well.
- the transformant can be analysed on RNA or protein species expected to be modified as a consequence of the presence of the transformed DNA.
- the number of functional gametes is relatively lower as a function of the number of haploid chromosomes.
- the % of functional gametes can be estimated by the formula (l/2) n x 100% in which n is the haploid chromosomal number.
- the % of seeds that are formed can be calculated by the same formula.
- DH production is used to improve efficiency of the present method.
- the production of diploid plants out of haploid spores is a tissue culture technique which is used widely in plant breeding to accelerate the production of plant which are completely homozygous.
- this technology is referred to as doubled haploid or DH technology.
- a haploid or monoploid plant only one genome is present once. This means that all genes are present in a hemizyous state.
- haploidy may be the predominant state; such is the case in the gametophyte of mosses. In crop plants however, haploidy is not the predominant state, except for the inconspicuous and parasitic gametophytes, the pollen grain, the pollen tube, and the embryo sac. Haploid plants are usually sterile because of univalent chromosomes. However, doubled haploids that are obtained either by spontaneous doubling of the haploid chromosome content or achieved by other means such as chromosome doubling agents are among the most valuable tools in plant breeding. Doubled haploid plants are genetically homozygous and therefore the ultimate pure breeding lines that can theoretically only be achieved by many generations of inbreeding.
- a haploid plant develops from haploid cells from an unfertilized ovule (gynogenesis) , or haploid cells from anthers (androgenesis) .
- the frequency of natural haploids is fairly low, about 1 per 1000 in the case of parthenogenesis and about 0.1 per 1000 in the case of androgenesis.
- in vitro tissue culture methods have been worked out over the years to provide plant breeders with sufficient numbers of doubled haploids in order to partially or completely replace inbreeding.
- Anther and microspore cultures are well established techniques which are used for the production of homozygous lines in many crop species, such as maize (Zea mays L.): Gaillard et al .
- Haploids and doubled haploids can also be derived from gametophytic cells of the ovary in barley (Hordeum vulgare L.)) (San Noeum L. (Ann. Amelior. Plantes 26, 751-754 (1976) ) .
- Doubled haploid production via ovary cells is suitable for crop species that are in many cases not amenable for anther or microspore culture. Examples are sunflower (Helianthus annuus L.) Gelebart P. and San L. Agronomie, 7, 81-86 (1987), sugar beet (Beta vulgaris L.) Hosemans D and Bossoutrot D. Z. convinced 91: 74-77 (1983), melon
- Doubled haploid plants derived from normal diploid donor plants are usually self pollinated and the resulting progeny is genetically identical and homogeneous, that is there should be no genetic segregation of alleles anymore.
- the combination of doubled haploid techniques with the suppression of crossing-over according to the invention provides very powerful new possibilities for plant breeding. All plants derived from doubled haploid techniques applied to plants (with any degree of heterozygosity) where crossing- over (chromosome recombination) is eliminated are fully homozygous.
- cucumber has 7 chromosomes as a haploid set.
- a donor plant is heterozygous for genes on all chromosomes, and no crossing- over takes place, there are 128 different doubled haploid genotypes that possibly can occur, two of them being identical to the original parental plants that constituted the donor plant, in case the donor plant was derived from a cross between two homozygous original parental plants.
- the number of DH or inbred plants produced has to be multiplied with a factor.
- a reasonable factor is 3-4, giving a 95-98% chance of finding the desired genotype.
- the amount of DHs that should be produced are still industrially applicable, whereas in traditional self-pollination, the number of descendants to be produced amounts to very high quantities, that normally will not fit within the scope of a commercial breeding program.
- Reconstruction of Fl hybrids by deducing the original parental ancestors and creating new parental lines can be useful in case one would like to develop alternative parents, that have better properties for seed or endosperm quality, for its commercial Fl seed production.
- the genetic constitution is not relevant, and irrespective of the fact whether the plant is a hybrid or a plant with unknown genetic composition.
- DH doubled haploid
- other lines are generated, that have 6 chromosomes from one starting line and 1 chromosome from the other starting line that normally would generate the donor material (as a haploid set) .
- the donor material used for recombination suppression and doubled haploids is an Fl hybrid that was created by crossing 2 homozygous lines (for instance derived from doubled haploids) and the said invention that is disclosed here is applied, then parental lines can be recovered that are identical to the two starting lines.
- the recombination frequency between 2 distinct genetic loci is used as a measure of genetic distance between these loci on a particular chromosome.
- the maximum frequency of recombination between any two genes is 50%, the same value that would be observed if the genes were on non-homologous chromosomes and assorted independently. 50% . recombination occurs when the genes are so far apart on the chromosome that at least one crossing-over almost always occurs between them.
- chemical treatment (s) or transgenic means whether or not stable or transient, all genes that reside on a particular chromosome are fixed in their respective allelic forms.
- genes or loci located at the outer ends of the chromosomes co-segregate. Co-segregation is easily monitored if the genes encode visual markers, but currently available DNA fingerprinting technology association studies between DNA markers and important genes and DNA markers per se enhance the resolving power of linkage analysis. Examples of such DNA fingerprinting technologies are RFLP (Restriction Fragment Length Polymorphism (Beckmann, J.S. and Soller, M. (1983) Theor. and Appl . Genet. 67, 35-43)), RAPD (Random Amplified Polymorphic DNA (Welsh, J. and McClelland, M. (1990) Nucleic Acids Res.
- RFLP Restriction Fragment Length Polymorphism
- RAPD Random Amplified Polymorphic DNA
- the invention relates to the improvement of efficiency for transfer of cytoplasmic male sterility in plants by using suppression of "crossing-over" or recombination.
- Cytoplasmic male sterility or CMS is a trait that is widely used in plant breeding. CMS is used for making Fl hybrid varieties in vegetable species such as carrot, cabbage, cauliflower, broccoli, brussels sprouts, chicory and endive, but also in agronomic species such as sugar beet and sunflower.
- CMS that is used in commercial plant breeding is inherited by the female parent, the phenotypic appearance of CMS (lack of pollen, brown anthers, petaloid anthers) can however also depend on nuclear factors that either may restore the male sterility or do not affect sterility (so called maintainers of CMS)
- maintainers of CMS In order to add the CMS trait to a specific fertile breeding line, the person skilled in the art knows that several back crosses are required in order to replace the majority of the nuclear genome from one line that harbours CMS by the genome that has to be converted to male sterility.
- the CMS donor line is maintained by back-crossing with isogenic male fertile line (s) .
- the CMS donor is made homozygous for a recessive mutation or a transgene that confers recombination suppression.
- the donor line is preferably genetically dissimilar from the line that has to be converted to male sterility for a large number of nuclear genetic markers so that the difference between the chromosomes of the CMS and the fertile donor can be more easily determined.
- a first cross is made by pollination of the said CMS homozygous recombination suppressed line with pollen of the desired line.
- the resulting Fl progeny contains CMS and 50% of the chromosomes of the desired line.
- a CMS line into a maintainer line for those plant species in which restorer genes reside within the germplasm like in Brassica sp., carrot and radish.
- a fertile plant containing nuclear restorer genes and normal, non-CMS cytoplasm is transformed with a construct that confers suppression of meiotic recombination.
- Transformants harbouring such construct preferably in a homozygous form are used as pollinator in a cross with a plant from a CMS line for which a maintainer line needs to be produced.
- the resulting hybrid plants will be male fertile as a consequence of the presence of the restorer genes and contain the construct in a heterozygous form.
- the chromosomes of the hybrid plants which are 50% derived from the original CMS line and 50% of the fertile plant containing the restorer genes, will not recombine during meiosis. Subsequently, such hybrid plant will be used as a pollinator in a cross with the original plant harbouring the restorer genes and the normal, non-CMS cytoplasm.
- progeny plants are selected which contain a full complement of the chromosomes originating from the original CMS line. These plants are then used to produce doubled haploid plants which are selected for a full complement of chromosomes from the original CMS line using the same molecular markers.
- the resulting plants can be used as maintainer for the original CMS line.
- DNA fingerprinting is used to improve efficiency of the present invention.
- DH technology is used in combination with suppression of recombination to obtain, in an efficient way, completely homozygous, diploid plants which have a full complement of chromosomes comprising a random combination of the chromosomes of the plants from which the double haploid plants were derived.
- the plants which are completely homozygous and which have a full complement of chromosomes comprising a random combination of the chromosomes of the plants in which meiotic recombination was suppressed can be identified using alternative approaches. These alternative approaches comprise DNA fingerprinting technologies, which enables the person skilled in the art to determine the level of polymorphisms that exists between genomes of any origin or complexity in a random fashion.
- seeds are produced by self-fertilization of a plant in which meiotic recombination is suppressed. The collection of these selfing seeds is used to grow the first inbred generation
- SI system for analyzing the total number of different genotypes that exists.
- the total number of different genotypes that exists is 0.5 (2 n - 2 n ) + 2 n , where n is the haploid number of chromosomes.
- n is the haploid number of chromosomes.
- 2 is the number of different but completely homozygous genotypes whereas all other plants are heterozygous for a variable number of chromosomes.
- DNA that is extracted from these plants is analysed by a DNA fingerprinting technology.
- the relative level of polymorphism's that is measured for each plant of the SI reflects the level of heterozygocity. This allows enriching the SI population for plants with a relatively high level of homozygocity.
- marker alleles which have a known position on the genetic map of a given crop species can be tested for polymorphisms within the plant in which meiotic recombination is suppressed.
- the identification of a single polymorphic marker allele per chromosome which can be measured in a co-dominant fashion is sufficient to identify the homozygous plants in the SI.
- this approach requires more input of resource when the crop species contains a higher haploid number of chromosomes.
- the frequency of homozygous plants in an SI is 2 n .
- homozygocity of a single marker allele is diagnostic for all loci on the same chromosome in terms of their homozygocity. This analysis allows identifying the homozygous plants in the SI and further allows classifying the homozygous lines in complementation groups. Two plants are considered complementary when upon crossing of these plants, the genotype of the plant in which recombination was suppressed is fully recovered.
- This analysis further allows producing Fl hybrids in which any predetermined set of chromosomes is present homozygously whereas all others are present heterozygously.
- endosperm or seed coat analysis from Fl hybrids can be used to determine maternal genotype.
- the availability of an assay to determine the presence of a minimum of one co-dominant marker allele per chromosome allows the determination of the zygocity of each chromosome of a plant of the SI population produced on a plant in which meiotic recombination is suppressed.
- those plants which have the same genotype as the mother plant of the plant in which meiotic recombination is suppressed can be identified by analyzing the DNA of the seed coat of the seed from which the plant was grown in which meiotic recombination is suppressed.
- the DNA in a seedcoat is of maternal origin and therefore, the available assays for the marker allele can be used to analyze the seedcoat DNA that reveals the identity of the maternal alleles.
- the data resulting from such analysis can be used to identify the homozygous plants in the Si which have a genotype identical to the mother plant of the plant in which meiotic recombination is suppressed.
- the plants which have the same genotype as the father plant are those plants which are fully complementary to the mother plant.
- the plants which have a genotype -identical to the mother and father plants can be identified by analyzing the endosperm of the seed from which the plant was grown in which meiotic recombination is suppressed.
- endosperm tissues the maternal genome is present in twofold over the paternal genome, a quantitative measurement of the presence of the marker alleles in a total nuclear DNA extract of the endosperm reveals the identity of the maternal and paternal alleles.
- the data resulting from such analysis can be used to identify the homozygous plants in the SI which have a genotype identical to the mother or father plant of the plant in which meiotic recombination is suppressed.
- 2n gametes from 2n parents arise by abnormalities during meiosis.
- second division restitution unreduced gametes arise by an incomplete second division.
- the result is a dyad where both 2n cells are separated by a reduction cell wall.
- Gametes that are produced in such a way are homozygous in the case of the absence of crossing-over and recombination.
- Plants regenerated from 2n gametes produced by said second division restitution in the absence of recombination are the functional equivalent of doubled haploid plants. For SDR see "fi.
- the invention is suitable for use in all non-human organisms, in particular in plants, especially in agriculture (potatoes, vegetables) and horticulture (vegetables, fruit, flowers) but also in potted plants, flower bed plants, shrubs, trees and fungi (mushrooms) .
- Crop plants that may be subjected to the method of the invention comprise maize, wheat, rice, sugar beet, oilseed rape, ryegrass, sunflower, soybean, tomato, cucumber, spinach, pepper, petunia, potato, tobacco, eggplant, melon, carrot, radish, lettuce, vegetable Brassica species (cabbage, cauliflower, broccoli, kohlrabi, Brussels sprouts), leak, bean, endive, chicory, onion, potato, strawberry, radish, fennel, table beet, celery.
- vegetative or clonal propagation is the exclusive or dominant way of commercial propagation.
- superior genotypes are identified in segregating populations, e.g.
- the genotype of the heterozygous clonally propagated plant can now be resynthesized and hybrid seeds with the said genotype provided.
- Starting organism heterozygous organism that is used as a starting material in the method of the invention.
- the starting organism is not necessarily the direct result of a cross between two parents, but if so these parents are called the "original parents” and a line of such original parents is called an "original parental line”.
- (New) parent a homozygous organism resulting from the method of the invention that can be used in a cross with a complementary (new) parent to reconstruct the original starting organism.
- a line of each (new) parent is called a " (new) parental line” .
- Genotype The genetic constitution of an individual organism.
- Target gene a gene residing within the genome of an organism which upon modification of its expression results in a meiotic process within said organism which is characterised by the formation of spores that contain a set of chromosomes which have not been subjected to meiotic recombination or which have been subjected to a reduced frequency of meiotic recombination as compared to the situation in which expression of said gene is not modified.
- Functional homologues Genes with the same or similar functions which can reside within one organism or can reside within organisms belonging to different biological species. Suppression of meiotic recombination: An event which leads to the reduction, preferably absence of exchange of chromosome fragments between two paired chromosomes during meiosis. The present invention is further elucidated in the
- Figure 1 Partial nucleotide sequence of BoDMCl (SEQ ID NO:l) .
- Figure 2 Partial nucleotide sequence of BcDMCl (SEQ ID NO:2) .
- Figure 3 Partial nucleotide sequence of LeDMCl (SEQ ID NO: 3) .
- Figure 4 Partial nucleotide sequence of SmDMCl
- Figure 5 Partial nucleotide sequence of NtDMCl (SEQ ID NO: 5) .
- Figure 6 Partial nucleotide sequence of BoSPOll (SEQ ID NO: 6) .
- Figure 7 Partial nucleotide sequence of BcSPOll (SEQ ID NO: 7) .
- Figure 8 Partial nucleotide sequence of AtMSH5 (SEQ ID NO: 8) .
- Figure 9 Result of a BLAST X analysis of the
- AtMSH5 partial nucleotide sequence showing the level of identity of the translated AtMSH5 sequence with known MSH5 orthologues (Sbjct) from Saccharomyces cerevisiae, Homo sapiens, Mus musculus and Caenorhabditis elegans .
- Figure 10 Map of pRZ51.
- RB right border
- LB left border
- spec spectinomycin/streptomycin resistance
- 35S pr CaMV 35S promoter
- Bc-DMC BcDMCl
- OCS-ter octopine synthase promoter
- Pnos nopaline synthase promoter
- NPTII neomycin phosphotransferase II
- Tnos nopaline synthase polyadenylation signal.
- Figure 11 Map of pRZ52.
- RB right border
- LB left border
- spec spectinomycin/streptomycin resistance
- 35S pr CaMV 35S promoter
- Bc-SPOll BcSPOll
- OCS-ter octopine synthase promoter
- Pnos nopaline synthase promoter
- NPTII neomycin phosphotransferase II
- Tnos nopaline synthase polyadenylation signal.
- FIG. 12 Map of pRZ54.
- RB right border
- LB left border
- spec spectinomycin/streptomycin resistance
- 35S pr CaMV 35S promoter
- AtMSH5 AtMSH5
- OCS-ter octopine synthase promoter
- Pnos nopaline synthase promoter
- NPTII neomycin phosphotransferase II
- Tnos nopaline synthase polyadenylation signal.
- Figure 13 Partial nucleotide sequence of BoMSH5
- Figure 14 Partial nucleotide sequence of LeMSH5 (SEQ ID NO: 18) .
- Figure 15 Partial nucleotide sequence of SmMSH5 (SEQ ID NO: 19) .
- Figure 16 Partial nucleotide sequence of NtMSH5 (SEQ ID NO: 20) .
- a fully heterozygous plant which contains a haploid chromosome number of n, is able to produce a maximum number of 2n genetically distinct gametes.
- progeny plants When such a plant is self- fertilised, progeny plants have a maximum genetic variability of 0.5(2 2n -2 n ) + 2 n different genotypes.
- DH technology in combination with suppression of meiotic recombination results exclusively in progeny plants, which are completely homozygous.
- progeny plants which are completely homozygous.
- the maximum number of genetically distinct diploid plants is identical to the maximum number of genetically distinct haploid gametes which can be produced by a plant in which meiotic recombination is suppressed which is 2n.
- Table 1 • The effect of DH technology on the efficiency of pure line recovery in a fully heterozygous plant (i.e. a plant that is heterozygous on every one of its chromosomes) in which meiotic recombination is suppressed, as a function of the haploid chromosomal number
- the present invention teaches the combined use of meiotic recombination suppression in combination with a technology for efficiency improvement like DH technology to enable the conversion of a heterozygous plant into an Fl hybrid variety by means of crossing parental lines obtained by the present invention as such.
- the analysis is shown of the probability of finding at least one complementary combination of two doubled haploid plants (a combination that after crossing can ⁇ resynthesize' the starting plant) , as a function of the haploid chromosomal number n of a given plant species and the number k of DH-plants produced from a heterozygous starting plant in which meiotic recombination is fully suppressed.
- n the maximum number of genotypes which are obtained from a plant of that crop species in which meiotic recombination is fully suppressed and from which double haploid plants are produced is 2n.
- the probability that one randomly chosen pair of double haploid plants from this population, upon crossing, results in an Fl hybrid which has a genotype identical to genotype in which recombination has been suppressed (original genotype) is 1/2 (because 2 n /(2 n ) 2 ).
- ⁇ _k- ( k-1 ) combinations can be made and therefore the probability that within this DH- population no complementary DH' s can be found is ( (2 n -l)/2 n ) (4 * (k - ⁇ ) and therefore the probability of that at least one complementary combination of two DH' s can be found i s l- ( ( 2 n - l ) /2 n ) ( i / 2k ( k -i ) ⁇
- This analysis shows that the original genotype is resynthesized as an Fl hybrid according to the present invention with high probability using 48 doubled haploid plants for cucumber, 128 for cauliflower and 256 for tomato, melon and sweet pepper.
- Total DNA is extracted from plant tissues using the Genelute Plant Genomic DNA Kit (Sigma-Aldrich, Zwijndrecht, the Netherlands) .
- the PCR reaction was carried out using a total amount of 30 ng DNA after which the reaction products were analysed on a 1% agarose gel.
- Total RNA is extracted from plant tissues using the commercially available RNeasy Plant Mini Kit from Qiagen (Valencia, CA, USA) .
- the purified RNA is subsequently treated with 1 ⁇ l of 10 units/ ⁇ l
- RT-PCR reaction is carried out using SuperscriptTM One-Step RT-PCR with platinum® Taq from Invitrogen (Breda, the Netherlands) , after which the reaction products are analysed on a 1% agarose gel. PCR products are cloned using the TOPO TA Cloning® system of Invitrogen (pCR®2.1-TOPO®) which is based on TA cloning and blue white colony screening.
- AtDMCl Based on the published gene sequence of DMCl of Arabidopsis thaliana, AtDMCl (GenBank Accession No. U76670) , a primer combination was developed consisting of the following nucleotide sequences: forward primer 5 ' -ACAGAGGCTTTTGGGGAATT-3 ' (SEQ ID NO: 9) and reverse complement primer 5'- ACAGAGGCTTTTGGGGAATT-3' $EQ ID NO: 10).
- PCR analysis revealed a 380 bp cDNA fragment by RT-PCR from flower buds of Arabidopsis thaliana and an 1100 bp fragment from genomic DNA of Arabidopsis thaliana. This result is expected based on the known genomic sequence of the AtDMCl gene.
- the same primer combination was used in an RT-PCR amplification reaction using RNA extracted from flower buds of Brassica oleraceae and Brassica carinata.
- a 380 bp cDNA fragment was obtained which was cloned and sequenced.
- the Brassica oleraceae DMCl gene is denominated BoDMCl and its nucleotide sequence of the 380 bp cDNA fragment is shown in Figure 1.
- the Brassica carina ta DMCl gene is denominated BcDMCl and its nucleotide sequence of the 380 bp cDNA fragment is shown in Figure 2.
- the same primer combination was used in a PCR amplification reaction using genomic DNA extracted from tissues of Lycopersicon esculentum, Solanum melongena and Nicotiana tabacum which resulted in specific amplification products of 1100 bp for all 3 plant species.
- These fragments have a length which corresponds well to the length of the genomic fragment of Arabidopsis thaliana and were denominated LeDMCl for Lycopersicon esculentum, SmDMCl for Solanum melongena and NtDMCl for Nicotiana tabacum.
- the fragments were cloned and sequenced, the result of which is shown in Figure 3 for LeDMCl, Figure 4 for SmDMCl and Figure 5 for NtDMCl.
- a BLAST analysis showed that the fragments contain regions with a high level of identity to AtDMCl cDNA.
- a primer combination was developed of which the primers correspond to a position of the Arabidopsis thaliana SPOll-1 (AtSPOll-1, ACCESSION AF-302928) genomic DNA which encodes a stretch of amino acids which is highly conserved between known SPOll orthologues of different species.
- the primers have the following nucleotide sequences: forward primer 5 ' -AACGGGTTGGTGATGGG-3 ' £EQ ID NO: 11) and reverse complement primer 5'- CCATATGGATCACAGTCAAC-3 ' $EQ ID NO: 12).
- PCR analysis revealed a 350 bp cDNA fragment by RT-PCR from flower buds of Arabidopsis thaliana.
- BcSPOll of which the nucleotide sequence of the 350 bp cDNA fragment is shown in Figure 7.
- a specific primer combination was made to amplify additional plant MSH5 sequences.
- This primer combination has the following sequence: forward primer 5'- TgTCCCGGCTGCATCGGCCAAAATCGGC-3 ' £EQ ID NO: 15) and reverse complement primer 5'- GAATTCGTCAATCAAAATCAGTGACCG-3 ' (SEQ ID NO: 16) and generates a fragment of 170 bp on Arabidopsis thaliana genomic DNA.
- This primer combination was then used in a PCR reaction using genomic DNA of Brassica oleraceae, Lycoperisicon esculentum, Solanum melongena and Nicotiana tabacum as template. For all plant species an amplified fragment of 170 bp was obtained.
- RNA interference RNA interference
- RNA interference In order to downregulate the activity of a target gene in a particular plant species, use is made of RNA interference.
- DNA fragments of the DMCl and SPOll of Brassica carina ta and the MSH5 gene of Arabidopsis thaliana are inserted into pKANNIBAL (Wesley et al (2001) The Plant Journal 27, 581-590) such that upon expression in plants an RNA molecule is formed which folds back upon itself thus forming a hairpin structure that triggers the specific degradation of homologous RNA.
- the vector pKANNIBAL contains an intron positioned downstream of the CaMV 35S promoter and upstream form an octopine synthase polyadenylation signal.
- a multiple cloning site is positioned which allows convenient insertion of the left and right arm of DNA corresponding to the RNA interference target in a inverted orientation relative to each other.
- the intron is removed by splicing and the left and right arm fold back on each other forming the double stranded RNA.
- the gene fragments are reamplified from the vectors in which they have been cloned using primers which are extended with recognition sites for Xhol hybridising at the 5 '-end of the gene fragment and Kpnl hybridising at the 3 ' -end of the gene fragment .
- the fragments which are generated by PCR using these primers is digested with Xhol and Kpnl and subsequently inserted in pKANNIBAL digested with Xhol and Kpnl.
- the resulting plasmids are denominated pRZ039 containing DMCl, pRZ040 containing SPOll and pRZ041 containing MSH5.
- the right arms are prepared similarly but using a different set of primers which generate a Xbal site at the 5' end of the gene fragment and a Hindlll site at the 3 '-end of the gene fragment.
- Upon digestion of the right arms they are inserted into the vectors containing the corresponding left arm resulting in pRZ042 for DMCl, pRZ043 for SPOll and pRZ044 for MSH5.
- the complete hairpin cassettes containing the DMCl, SPOll and MSH5 sequences as inverted repeat, are inserted separately as a Notl fragment into the Notl site of a T-DNA of a binary vector called pART27 which contains the neomycin phosphotransferase II gene as selectable marker for plant transformation.
- pART27 binary vector which contains the neomycin phosphotransferase II gene as selectable marker for plant transformation.
- the resulting binary vectors, denominated pRZ051 for DMCl ( Figure 10) , pRZ052 for SPOll ( Figure 11) and pRZ054 for MSH5 ( Figure 12) are transferred into Agrobacterium tumefaciens using a triparental mating procedure with the helper plasmid pRK2013 (Ditta et al (1980) Proc. Natl. Acad. Sci. USA 77, 7347-7351) . Because of the high level of sequence identity of the BcDMCl and BcSPOll and the AtMSH5 sequence with the respective orthologous genes, the constructs are effective in the downregulation of the target genes within all species of the Cruciferaceae family.
- pRZ051 are also effective in solaneceous species.
- the BcDMCl sequences can be used even more broadly i.e. also in monocotyledonous plant species like for instance rice, wheat, barley and maize.
- the above described method can be used to make constructs containing DNA fragments which are homologous to other target genes that need to be downregulated.
- Agrobacterium tumefaciens strain C58 (ATTC 33970) containing either one of the plant transformation vectors pRZ051, pRZ052 or pRZ054 is grown overnight in LB medium containin-g streptomycin (100 mg/L) and spectinomycin (300 mg/L) to select for the vectors and rifampicin (40 mg/L) and gentamycin (25 mg/L) to select for the Agrobacterium tumefaciens C58 background at 29°C.
- the floral dip method is used, as described by Desfeux et al . (2000) Plant Physiology 123, 895-904.
- the bacterial cells are resuspended in floral dip solution (50 g sucrose + 500 ⁇ l Silwett L-77 surfactant (Helena Chemical Co p. Fresno, CA, USA) per liter MillipTM (Millipore, Etten-Leur, the Netherlands) .
- Bolting plants, containing multiple floral buds, are submerged into the dipping solution containing the Agrobacterium cells at an Optical Density (OD) between 1.0 and 1.5 during 5-10 seconds with gentle agitation.
- OD Optical Density
- the plants are contained in a plastic container to keep high humidity under low light conditions for a day and subsequently, seeds are grown on the plants .
- Transformants are selected by germinating surface sterilised seeds in 0.1 % agarose layered upon half-strength MS plates containing 50 mg/L kanamycin. Kanamycin resistant seedlings are transferred to soil in a greenhouse. In total 51 kanamycin resistant seedlings/construct were grown to mature plants which were analysed by PCR for the presence of the T-DNA. Primer combinations were designed which specifically amplify either the NPTII gene (NEO-FORW + NEO-REV) , the region from the CaMV 35S promoter to the intron (35S-F1 + RNAi-intr-Rl) and the region from the intron to the OCS terminator (RNAi-intr-Fl + OCS-Rl) .
- Example 4 Constructs The constructs described in Example 4 were used for the transformation of various crop plants by means of Agrobacterium. Arabidopsis constructs can be used in Brassica. Optionally, the genes of the constructs of Example 4 can be exchanged with the homologous endogenous gene of the relevant crop as given in the description. In addition, functional homologues can be used.
- microspores respectively egg cells did however contain a normal, functional haploid set of chromosomes that results from a meiosis where no or little recombination has taken place (as compared to wild type) .
- These haploid microspores respectively egg cells are the starting material for making doubled haploids.
- Haploids in maize are obtained from microspores as described by Pescitelli S and Petolino J (1988) Plant Cell Reports 7: 441-444; Cou ans M et al . , (1989) Plant Cell Reports 7: 618-621; Pescitelli S et al . , (1989) Plant Cell Reports 7: 673-676. Buter B (1997) In: In Vitro Haploid Production in Higher plants, vol 4, 37-71. Kluwer Academic Publishers. Eds. S Jain, S Sopory & R Veilleux.
- diploid plants are produced from haploid plants by either spontaneous diploidization or chemically.
- plants are selected that contain a single copy of the transgene. Due to reduction or elimination of recombination during meiosis some of these plants are homozygous for all alleles. On average, 50% of those doubled haploids contain the transgene that confers the recombination downregulation whereas 50% is free of transgenic nucleic acids.
- haploid maize plants were produced following natural and artificial pollination with a haploid inducer as described by Rotarenco V (2002) Maize Genetics Cooperation News Letter 76: 16. In this case seeds were obtained that contain haploid embryos. Also in this case, only haploids that have lost the transgene due to segregation from the hemizygous donor material are retained.
- Chromosome doubling is performed as described by Wan, Y & Widholm, J (1995) Z.
- Devader technology Plants that contain one copy of the transgene (established by means of Southern blot or so-called Invader technology) are withheld for use in crosses in order to avoid repetitive transformation events.
- preferentially regenerants containing one copy of the inhibitory DNA are further used for making doubled haploids by means of anther culture, microspore culture and ovary culture according to Gosal S et al., (1997) In: In Vitro Haploid Production in Higher plants, vol 4, 1-35. Kluwer Academic Publishers. Eds. S Jain, S Sopory & R Veilleux.
- DNA construct conferring inhibition of recombination during meiosis are retained and used as starting material for making doubled haploids according to Keller E and Korzun L. (1996) In: In Vitro Haploid Production in Higher plants, vol 3, 51-75. Kluwer Academic Publishers. Eds. S Jain, S Sopory & R Veilleux.
- diploid plants are produced from haploid plants by either spontaneous diploidization or chemically.
- Cucumber with a haploid chromosome number of 7 is also a crop species where the invention is very powerful.
- the silencing constructs are introduced by means of Agrobacterium transformation in embryogenic callus as disclosed in EP-
- haploids are produced by means of gynogenesis as described in EP 0 374 755.
- diploid plants are produced from haploid plants by either spontaneous diploidization or chemical y.
- Transformation of various Brassica species is performed according to Moloney M et al., ((1989) Plant Cell Reports 8, 238-242) for Brassica napus; Metz T et al . , ((1995) Plant Cell Reports 15, 287-292) for broccoli
- Doubled haploids were prepared according to Palmer
- CMS is one of the most prominent tools for plant breeding in the production of Fl hybrid varieties.
- farmers demand a uniform phenotype (and therefore preferentially genotype) of the plant from the seeds they buy. In order to achieve this, self pollination of the seed producing plant has to be excluded. In order to do this emasculation of the female line by hand is required which is a costly and error prone activity.
- crops natural male sterility offers a better and more efficient alternative.
- crops are for instance but not limited to rice, sugar beet, carrot, and Brassica spp. Until 1970 nearly all of the hybrid corn was produced using T cytoplasm for Fl production.
- a selected pure line as a result of traditional plant breeding or obtained by the aid of doubled haploid methodology that has been propagated by self-fertilization is converted to male sterility by making a cross of this line to a line that is a carrier of cytoplamatic sterility.
- the pollinator and the CMS donor are characterized genetically by using genetic markers such as but not limited to AFLP, RFLP, RAPD, Invader etc as is well known to the persons skilled in the art.
- the male sterile line is suppressed for recombination, as exemplified in the other examples.
- lines are selected that are homozygous for the transgene.
- the Fl progeny that results from the cross of the pollinator with the CMS acceptor inherits 50% of the chromosomes form both parents.
- Egg cells produced by plants of this generation are formed in the absence of recombination which means that when- the haploid chromosome number is 9 which is the case for cauliflower, carrot and sugar beet, 1 egg cell in 512 of the egg cells that contain a full chromosome set inherits exactly the same chromosomal constitution as the egg cells or the pollen from the pollinator. This means that after successful pollination already the second back cross gives rise to seeds in which the chromosomal content of the original pollinator has been transferred in the cytoplasmic environment of the CMS line.
- a maintainer or B-line of Daucus carota , Brassica olera cea or Raphanus sa tivus was produced starting from a homozygous cytoplasmic male sterile line or A-line using the present invention.
- CMS mother lines are used to produce hybrid seeds.
- the CMS mother line (A-line) is maintained by backcrossing with a line that has the same or highly similar nuclear constitution, but has normal plasma, and thus is male fertile (B-line) .
- B-line male fertile
- a new A-line is produced by crossing elite male fertile genotypes with CMS-plants, choosing those combinations that maintain the CMS in the offspring (B-lines, i.e.
- N normal, fertile cytoplasm
- Seeds of Brassica oleraceae are surface sterilised by submerging them for 30 minutes in 6% solution of hypochlorite (commercial bleach, . 1.5% NaOCl final concentration) after which they are thoroughly rinsed with sterile milliQ. Subsequently, the seeds are germinated on sterile, wet filter paper. The germinated seeds which show the primary root are soaked into a 70 mmol/L caffeine solution for a period of 2 hours after which the seeds were rinsed with sterile milliQ.
- hypochlorite commercial bleach, . 1.5% NaOCl final concentration
- the seeds are allowed to recover by placing them on sterile, wet filter paper for 24 hours.
- the optimal treatment for different plant species can differ and should be established by testing different concentrations of caffeine, different incubation times and different recovery times.
- the meristematic cells are taken into tissue culture by preparing the root tips and transferring them onto MS-medium containing 0.5 ⁇ g/1 2,4-D (2,4 dichlorophenoxy acetic acid) into the dark for a period of 2 weeks to induce callus. After this callus induction, plants are regenerated by placing the callus onto medium containing 0.5 mg/L BA (16/8 hours light/dark, 25 °C) .
- the shoots are analysed molecularly for the presence of each of the haploid chromosomes by using genetic markers for each chromosome, preferably markers that are polymorph for each set of chromosomes.
- Haploid shoots containing a full complement of chromosomes are doubled by treatment with colchicine.
- Reverse breeding by chemical induction of aneuploidy followed ' by selection of haploid plants containing a complete set of chromosomes Flowering plants of Brassica oleraceae which contain young floral buds which are in a pre-meiotic state are treated with different chemical compounds known to induce aneuploidy selected from etoposide, podophyllin, benomyl, maleic hydrazide, atrazine, butachlor, APM, griseofulvin, vinblastin- sulphate, diazepam, colchicine, cadmiumchloride, econazole, pyrimethamine, thiabendazole, thimerozal or nocodazole according to C.B.S.R.
- the chemical is applied by dipping the pre-meiotic floral buds into a solution or by spraying a solution onto the pre-meiotic floral buds.
- the treatment is repeated a number of times to enhance the probability of exposing the appropriate developmental stage for a maximal number of floral buds.
- the solution contains a surfactant like Agralin (Syngenta, Roosendaal, the Netherlands) (0.25 ml/100 ml).
- the treated buds are labelled and grown to the stage optimal for microspore regeneration which on average occurs when the buds have a length of approximately 3 millimetre.
- Purified microspores are harvested from these buds and given a stress treatment of 2 days at 32 °C which is optimal to induce sporophytic development of the haploid cells.
- vegetative or clonal propagation is the exclusive or dominant way of commercial propagation.
- superior genotypes are identified in segregating populations, e.g. in an F2, and these are then maintained and multiplied by vegetative multiplication techniques, which are well known to the person skilled in the art.
- vegetative multiplication techniques which are well known to the person skilled in the art.
- the method of vegetative propagation of (heterozygous) plants has become dominant because production of hybrid varieties through seeds (as is done in many annual and biannual crops) first requires several generations of inbreeding of parental lines, which in many woody and tree species would take too much time for any commercial program.
- vegetative propagation superior genotypes are multiplied into a stock of genetically identical plants, and no time is "lost" to produce parental lines as is the case in seed-propagated hybrid crops.
- the genotype of the heterozygous clonally propagated plant can now be resynthesized and hybrid seeds with the said genotype provided.
- this hybrid can be resynthesized using lines which differ from the original maternal and paternal lines. By selecting a combination of lines which allows the production of commercial seeds of both high quality and quantity, the commercialisation of the hybrid becomes economically feasible or more attractive.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Environmental Sciences (AREA)
- Physiology (AREA)
Abstract
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002333716A AU2002333716B2 (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
CA2454609A CA2454609C (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
ES02796278T ES2407831T3 (en) | 2001-08-23 | 2002-08-23 | Inverse Genetic Improvement |
JP2003522290A JP4347689B2 (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
US10/487,468 US8242327B2 (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
IL16045402A IL160454A0 (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
EP02796278A EP1418804B1 (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
MXPA04001563A MXPA04001563A (en) | 2001-08-23 | 2002-08-23 | Reverse breeding. |
IL160454A IL160454A (en) | 2001-08-23 | 2004-02-18 | Method of reverse breeding, product and use thereof |
IL199944A IL199944A (en) | 2001-08-23 | 2009-07-19 | Seeds obtained by reverse breeding |
US13/253,697 US8692067B2 (en) | 2001-08-23 | 2011-10-05 | Reverse breeding |
US13/792,125 US20130298286A1 (en) | 2001-08-23 | 2013-03-10 | Reverse Breeding |
US14/177,751 US9518257B2 (en) | 2001-08-23 | 2014-02-11 | Reverse breeding |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01203193 | 2001-08-23 | ||
EP01203193.6 | 2001-08-23 | ||
EP02075582 | 2002-02-12 | ||
EP02075582.3 | 2002-02-12 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/487,468 A-371-Of-International US8242327B2 (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
US13/253,697 Continuation US8692067B2 (en) | 2001-08-23 | 2011-10-05 | Reverse breeding |
US10487468 A-371-Of-International | 2012-08-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003017753A2 true WO2003017753A2 (en) | 2003-03-06 |
WO2003017753A3 WO2003017753A3 (en) | 2003-09-04 |
Family
ID=26076981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/009526 WO2003017753A2 (en) | 2001-08-23 | 2002-08-23 | Reverse breeding |
Country Status (9)
Country | Link |
---|---|
US (4) | US8242327B2 (en) |
EP (2) | EP1418804B1 (en) |
JP (2) | JP4347689B2 (en) |
AU (1) | AU2002333716B2 (en) |
CA (1) | CA2454609C (en) |
ES (2) | ES2596627T3 (en) |
IL (3) | IL160454A0 (en) |
MX (1) | MXPA04001563A (en) |
WO (1) | WO2003017753A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006094773A3 (en) * | 2005-03-03 | 2007-02-15 | Rijk Zwaan Zaadteelt En Zaadha | Near reverse breeding |
JP2008531030A (en) * | 2005-03-03 | 2008-08-14 | ライク・ズワーン・ザードテールト・アン・ザードハンデル・ベスローテン・フェンノートシャップ | Reverse descendant mapping method |
EP2554045A1 (en) | 2011-08-04 | 2013-02-06 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Method for systemically influencing processes in the male meiocyte |
EP2574234A1 (en) | 2011-09-29 | 2013-04-03 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Quartet breeding |
EP2679089A1 (en) | 2012-06-29 | 2014-01-01 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Line design |
WO2014076249A1 (en) * | 2012-11-15 | 2014-05-22 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Reverse synthesis of breeding lines |
WO2016005467A1 (en) | 2014-07-08 | 2016-01-14 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Method for making chromosome substitution libraries |
US9681615B2 (en) | 2013-06-20 | 2017-06-20 | Elwha Llc | Rapid breeding of plants |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2596627T3 (en) * | 2001-08-23 | 2017-01-11 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Inverse genetic improvement |
JP2010259329A (en) * | 2009-04-28 | 2010-11-18 | Kozo Masuda | Non-heading brussels sprouts and method for making the same |
JP2011083260A (en) * | 2009-10-19 | 2011-04-28 | Chubu Electric Power Co Inc | Chrysanthemum plant and method for creating the same |
FR2980212A1 (en) * | 2011-09-16 | 2013-03-22 | Agronomique Inst Nat Rech | INCREASE IN MEIOTIC RECOMBINATION IN PLANTS BY INHIBITION OF FANCM PROTEIN |
CN104169296A (en) | 2012-03-13 | 2014-11-26 | 先锋国际良种公司 | Genetic reduction of male fertility in plants |
MX2014011037A (en) | 2012-03-13 | 2015-05-15 | Pioneer Hi Bred Int | Genetic reduction of male fertility in plants. |
US9783814B2 (en) | 2012-03-13 | 2017-10-10 | Pioneer Hi-Bred International, Inc. | Genetic reduction of male fertility in plants |
EP2754667A1 (en) * | 2013-01-11 | 2014-07-16 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Reversible genic male sterility in compositae |
CN103548670B (en) * | 2013-10-29 | 2016-01-20 | 南通新禾生物技术有限公司 | Utilize the reverse molecular breeding method of all matter of corn hybridization |
CN108291234A (en) | 2015-09-04 | 2018-07-17 | 主基因有限公司 | Multiple sporinite forms gene |
BR112021023769A2 (en) | 2019-05-29 | 2022-01-11 | Keygene Nv | gene for parthenogenesis |
CN112219716A (en) * | 2020-10-09 | 2021-01-15 | 连云港市农业科学院 | Simple method for preparing hybridization combination in onion field |
CN116568131A (en) | 2020-10-13 | 2023-08-08 | 主基因有限公司 | Modified promoters of parthenogenesis genes |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994021794A1 (en) * | 1993-03-22 | 1994-09-29 | Zeneca Limited | Dna, dna constructs, cells and plants derived therefrom |
AR013633A1 (en) * | 1997-04-11 | 2001-01-10 | Calgene Llc | METHOD FOR THE ALTERATION OF THE COMPOSITION OF AVERAGE CHAIN FAT ACIDS IN VEGETABLE SEEDS THAT EXPRESS A THIOESTERASE THAT PREFERS HETEROLOGICAL VEGETABLE AVERAGE CHAIN. |
JPH11318249A (en) * | 1998-05-19 | 1999-11-24 | Japan Tobacco Inc | Raising of seed production parent of f1 seed |
AU764176B2 (en) | 1998-09-09 | 2003-08-14 | Northwest Plant Breeding Company | Methods for generating doubled haploid plants |
EP1206524A4 (en) * | 1999-08-26 | 2004-09-29 | Northwest Plant Breeding Co | Methods for generating doubled haploid plants |
US20020151057A1 (en) | 1999-08-26 | 2002-10-17 | Yuanming Zheng | Methods for generating doubled haploid maize plants |
ES2596627T3 (en) * | 2001-08-23 | 2017-01-11 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Inverse genetic improvement |
-
2002
- 2002-08-23 ES ES10184079.1T patent/ES2596627T3/en not_active Expired - Lifetime
- 2002-08-23 CA CA2454609A patent/CA2454609C/en not_active Expired - Lifetime
- 2002-08-23 JP JP2003522290A patent/JP4347689B2/en not_active Expired - Lifetime
- 2002-08-23 ES ES02796278T patent/ES2407831T3/en not_active Expired - Lifetime
- 2002-08-23 AU AU2002333716A patent/AU2002333716B2/en not_active Expired
- 2002-08-23 IL IL16045402A patent/IL160454A0/en unknown
- 2002-08-23 EP EP02796278A patent/EP1418804B1/en not_active Expired - Lifetime
- 2002-08-23 MX MXPA04001563A patent/MXPA04001563A/en active IP Right Grant
- 2002-08-23 EP EP10184079.1A patent/EP2363019B1/en not_active Expired - Lifetime
- 2002-08-23 US US10/487,468 patent/US8242327B2/en active Active
- 2002-08-23 WO PCT/EP2002/009526 patent/WO2003017753A2/en active Application Filing
-
2004
- 2004-02-18 IL IL160454A patent/IL160454A/en active IP Right Review Request
-
2009
- 2009-06-01 JP JP2009131984A patent/JP4674262B2/en not_active Expired - Lifetime
- 2009-07-19 IL IL199944A patent/IL199944A/en active IP Right Grant
-
2011
- 2011-10-05 US US13/253,697 patent/US8692067B2/en not_active Expired - Lifetime
-
2013
- 2013-03-10 US US13/792,125 patent/US20130298286A1/en not_active Abandoned
-
2014
- 2014-02-11 US US14/177,751 patent/US9518257B2/en active Active
Non-Patent Citations (17)
Title |
---|
AN, Y.Q., PLANT J., vol. 10, 1996, pages 107 - 121 |
CADDICK, M.X. ET AL., NAT. BIOTECHNOL., vol. 16, 1998, pages 177 - 180 |
COLBERT, T., PLANT PHYSIOL., vol. 126, 2001, pages 480 - 484 |
CUNILLERA, N. ET AL., PLANT MOLEC. BIOL., vol. 44, 2000, pages 474 - 485 |
DRAKAKAKI, G. ET AL., TRANSGENIC RES., vol. 9, 2000, pages 445 - 452 |
GRELON, M., EMBO J., vol. 3, 2001, pages 589 - 600 |
HERMSEN J.: "The potential of meiotic polyploidization in breeding allogamous crops", IOWA STATE J. RES, vol. 58, no. 4, 1984, pages 421 - 435 |
HUANG, S. ET AL., PLANT MOLEC. BIOL., vol. 33, 1997, pages 125 - 139 |
HUNT, A.G.; MACDONALD M.H., PLANT MOLEC. BIOL., vol. 13, 1989, pages 125 - 138 |
J. SNEEP; A. HENDRIKSEN: "Pudoc", 1979, CENTRE FOR AGRICULTURAL PUBLISHING AND DOCUMENTATION WAGENINGEN |
KLIMYUK, V.I.; JONES, J.D., PLANT J., vol. 11, 1997, pages 1 - 14 |
LI, X. ET AL., 12TH INTERNATIONAL CONFERENCE ON ARABIDOPSIS RESEARCH, 2001 |
MACDONALD ET AL., NUCLEIC ACIDS. RES., vol. 19, 1991, pages 5575 - 5581 |
MCELROY, D. ET AL., PLANT CELL, vol. 2, 1990, pages 163 - 171 |
MOK D; PELOQUIN S., HEREDITY, vol. 35, 1975, pages 295 - 302 |
ODELL, J.T. ET AL., NATURE, vol. 313, 1985, pages 810 - 812 |
SCHENA, M. ET AL., PORC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 10421 - 10425 |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130298272A1 (en) * | 2005-03-03 | 2013-11-07 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Near Reverse Breeding |
WO2006094773A3 (en) * | 2005-03-03 | 2007-02-15 | Rijk Zwaan Zaadteelt En Zaadha | Near reverse breeding |
JP2008538074A (en) * | 2005-03-03 | 2008-10-09 | ライク・ズワーン・ザードテールト・アン・ザードハンデル・ベスローテン・フェンノートシャップ | Near-reverse breeding methods and organisms |
US7860658B2 (en) * | 2005-03-03 | 2010-12-28 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Reverse progeny mapping |
EP2301326A1 (en) | 2005-03-03 | 2011-03-30 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Near reverse breeding |
EP2366792A1 (en) * | 2005-03-03 | 2011-09-21 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Reverse progeny mapping |
US8165822B2 (en) | 2005-03-03 | 2012-04-24 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Reverse progeny mapping |
JP2013117535A (en) * | 2005-03-03 | 2013-06-13 | Rijk Zwaan Zaadteelt En Zaadhandel Bv | Inverse offspring mapping method |
US9332697B2 (en) | 2005-03-03 | 2016-05-10 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Near reverse breeding |
US9326463B2 (en) | 2005-03-03 | 2016-05-03 | Rijk Zw Aan Zaadteelt En Zaadhandel B.V. | Near reverse breeding |
JP2008531030A (en) * | 2005-03-03 | 2008-08-14 | ライク・ズワーン・ザードテールト・アン・ザードハンデル・ベスローテン・フェンノートシャップ | Reverse descendant mapping method |
EP2554045A1 (en) | 2011-08-04 | 2013-02-06 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Method for systemically influencing processes in the male meiocyte |
WO2013017683A1 (en) | 2011-08-04 | 2013-02-07 | Rijk Zwaan Zaadteelt En Zaadhandel B.V | Method for systemically influencing processes in the male meiocyte |
CN103957698A (en) * | 2011-09-29 | 2014-07-30 | 瑞克斯旺种苗集团公司 | Quartet breeding |
EP2574234A1 (en) | 2011-09-29 | 2013-04-03 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Quartet breeding |
US9750205B2 (en) | 2011-09-29 | 2017-09-05 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Quartet breeding |
WO2013045616A1 (en) | 2011-09-29 | 2013-04-04 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Quartet breeding |
EP2679089A1 (en) | 2012-06-29 | 2014-01-01 | Rijk Zwaan Zaadteelt en Zaadhandel B.V. | Line design |
WO2014001467A1 (en) | 2012-06-29 | 2014-01-03 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Line design |
CN104411158A (en) * | 2012-06-29 | 2015-03-11 | 瑞克斯旺种苗集团公司 | Line design |
US10785929B2 (en) | 2012-06-29 | 2020-09-29 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Line design |
WO2014076249A1 (en) * | 2012-11-15 | 2014-05-22 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Reverse synthesis of breeding lines |
US9681615B2 (en) | 2013-06-20 | 2017-06-20 | Elwha Llc | Rapid breeding of plants |
WO2016005467A1 (en) | 2014-07-08 | 2016-01-14 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Method for making chromosome substitution libraries |
Also Published As
Publication number | Publication date |
---|---|
MXPA04001563A (en) | 2004-10-27 |
US20130298286A1 (en) | 2013-11-07 |
JP2005500069A (en) | 2005-01-06 |
US20060179498A1 (en) | 2006-08-10 |
US8692067B2 (en) | 2014-04-08 |
US8242327B2 (en) | 2012-08-14 |
US9518257B2 (en) | 2016-12-13 |
WO2003017753A3 (en) | 2003-09-04 |
JP4674262B2 (en) | 2011-04-20 |
EP2363019B1 (en) | 2016-08-10 |
US20120131688A1 (en) | 2012-05-24 |
IL160454A (en) | 2011-04-28 |
US20140259208A1 (en) | 2014-09-11 |
CA2454609A1 (en) | 2003-03-06 |
ES2596627T3 (en) | 2017-01-11 |
IL160454A0 (en) | 2004-07-25 |
EP2363019A3 (en) | 2011-11-23 |
CA2454609C (en) | 2016-06-28 |
JP4347689B2 (en) | 2009-10-21 |
EP2363019A2 (en) | 2011-09-07 |
IL199944A (en) | 2015-04-30 |
EP1418804A2 (en) | 2004-05-19 |
EP1418804B1 (en) | 2013-04-03 |
ES2407831T3 (en) | 2013-06-14 |
AU2002333716B2 (en) | 2008-07-17 |
JP2009225803A (en) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9518257B2 (en) | Reverse breeding | |
AU2002333716A1 (en) | Reverse breeding | |
US20200140874A1 (en) | Genome Editing-Based Crop Engineering and Production of Brachytic Plants | |
JP7273919B2 (en) | Parthenocarpic plant and method for producing the same | |
CN111836895A (en) | Compositions and methods for increasing crop yield through trait stacking | |
KR20230098337A (en) | Parthenocarpic Watermelon Plant | |
WO2022026849A1 (en) | Inir19 transgenic soybean | |
JP2013128484A (en) | Near reverse breeding method | |
US10785929B2 (en) | Line design | |
US20240141369A1 (en) | Domestication of a legume plant | |
US20230203513A1 (en) | Cucumber plant habit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002796278 Country of ref document: EP Ref document number: 2454609 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002333716 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 160454 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/001563 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003522290 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002796278 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006179498 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10487468 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10487468 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2002333716 Country of ref document: AU Date of ref document: 20020823 Kind code of ref document: B |
|
WWE | Wipo information: entry into national phase |
Ref document number: 199944 Country of ref document: IL |